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ABSTRACT 
Pumilio Proteins Regulate Translation in Embryonic Stem Cells and are Essential 
for Early Embryonic Development 
Katherine E. Uyhazi 
2012 
Embryonic stem (ES) cells are defined by their dual abilities to self-renew and to 
differentiate into any cell type in the body. This vast potential is precisely controlled by 
spatial and temporal gene regulation at transcriptional, post-transcriptional, and 
epigenetic levels. Recent studies have revealed several transcription factors that are 
essential for stem cell self-renewal and pluripotency, but the role of translational control 
in ES cells is poorly understood. Translational control is a fundamental mechanism of 
gene regulation during early development, and likely explains the discrepancies between 
the transcriptome and proteome profiles of stem cells and their differentiated progeny. 
Pumilio proteins are well-characterized RNA-binding translational repressors that are 
required for germline stem cell maintenance in Drosophila. However, relatively little is 
known about the two mammalian Pumilio proteins, Pumilio 1 (Puml) and Pumilio 2 
(Pum2). In this dissertation I characterize the mRNA targets, protein partners, and in 
vitro and in vivo function of Puml and Pum2. 
Puml - and Pum2-deficient mouse embryonic stem cell (mES) lines and 
conditional knockout mice were generated as a means to unravel the function of Pumilio 
proteins in ES cells and during early development. Puml -/- and Pum2 -/- ES cells grow 
more slowly than wild type ES cells but remain self-renewing and pluripotent. Puml-/-
1 
and Pum2 -/- mice are fertile and viable. Puml-/- mice are smaller than their littermates, 
have a hunched appearance that becomes more prominent with age, frequently develop 
ulcerative dermatitis, and have disorganized, blunted intestinal villi compared to wild 
type mice. Puml+/-;Pum2-/- mice are viable, Puml-/-; Pum2 +/- mice are born alive but 
have no oral intake and die within 24 hours, and Pum 1-/-; Pum2 -/- double knockout 
animals are embryonic lethal by e8.5. 
Puml and Pum2 are highly expressed in the cytoplasm of mES cells. RNA 
Immunoprecipitation-Microarray (RIP-Chip) analysis of mES lysate reveals that Puml 
binds to 1947 mRNAs and Pum2 binds to 437 mRNAs that comprise almost a complete 
subset of Puml targets. Transcription factors, genes involved in cell cycle control, and 
genes involved in embryonic patterning are significantly enriched among the mRNA 
targets of both Puml and Pum2. Several targets including Cyclin E, Cyclin Bl, and 
Pum2 are translationally repressed by Pum 1, as indicated by changes in protein level 
without corresponding changes in mRNA level. In mES cells, Puml is part of a -450 
kDa protein complex and Pum2 is part of a -350 kDa complex as shown by size 
exclusion chromatography. Co-immunoprecipitation and mass spectrometry were used to 
identify three novel binding partners of Puml: Anaphase-promoting complex subunit 1 
(APC1), Regulator of nonsense transcripts 1 (RENT1), and Zinc Finger Protein 198 
(ZNF198). Overall, this study reveals an essential function of mammalian Pumilio 
proteins during early embryogenesis, identifies mRNA targets that are translationally 
controlled by Puml and Pum2 in mES cells, and suggests novel protein-protein 
interactions that lend insight into the mechanism of action of Pumilio-mediated 
translational repression. 
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Embryonic Stem Cells and Translational Control 
Embryonic stem (ES) cells have the potential to differentiate into any cell type in 
the body and hold great promise for regenerative medicine. An understanding of the 
complex biology underlying stem cell self-renewal and differentiation is necessary in 
order to harness the power of these cells for applications in disease treatment and clinical 
therapy. What are the mechanisms that maintain stem cells in an undifferentiated, 
pluripotent state? What signals initiate stem cell differentiation, and how does the cell 
regulate gene expression to adopt a particular fate? Although recent work has elucidated 
some of the key factors and signaling cascades involved in these pathways, the basic 
mechanisms that regulate the balance between self-renewal and differentiation remain 
poorly understood. 
The transcription factors Oct4, Sox2, and Nanog are essential during early 
development and play a central role in the transcriptional circuitry of ES cells (Boyer et 
al. 2005). These factors regulate the expression of other transcription factors, which in 
turn control downstream networks of cell fate determination. However, the level of gene 
transcription does not necessarily reflect the level of protein expression in ES cells 
(Chang and Stanford 2008, Sampath et al. 2008), indicating that translational regulation 
provides an additional layer of control. In fact, when mouse ES cells are induced to 
differentiate by downregulation of the pluripotency factor Nanog, changes in mRNA 
expression are significantly different from the corresponding changes in protein 
expression. Lemischka and colleagues elegantly demonstrated this in 2009 by measuring 
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histone acetylation, chromatin-bound RNA polymerase II, mRNA levels, and nuclear 
protein levels during a five-day course of differentiation to determine the proportion of 
genes regulated by chromatin modification, transcriptional regulation, and translational 
regulation (Figure 1, Lu et al. 2009). They found that 13% of the genes encoding nuclear 
proteins were regulated at the level of chromatin modification, 44% were regulated at the 
level of transcriptional control, and surprisingly, almost 43% had discordant mRNA 
levels compared to protein levels, indicating that these were regulated at the level of 
translational control (Lu et al. 2009). Although historically most efforts have focused on 
transcription factors involved in embryonic stem cell self-renewal, these data highlight 
the importance of translational regulation of these pathways and suggest that translational 
control proteins may be key components of stem cell self-renewal and fate determination. 
Therefore, I have chosen to focus this dissertation on the role of the translational control 
Pumilio proteins in mouse ES cells and during early embryonic development. 
Translational regulation is a fundamental mechanism of gene regulation during 
early development, particularly when localized expression of proteins is required or when 
zygotic transcription is silenced (Gebauer and Hentze 2004). Translational regulation is 
also involved in diverse developmental processes such as stem cell proliferation, sex 
determination, metabolism, and neurogenesis (Kuersten and Goodwin 2003, Gebauer and 
Hentze 2004). Translational control affects the stability, localization, or translation of 
mRNAs present in the cells and can act in a global or RNA-specific manner. In general, 
the main mechanisms of translational control involve modulation of mRNA stability, 
translational initiation, or translational elongation. One common way in which mRNA 
13 
Mouse ESC line Differentiating cells 
HIS POL RNA PRO 
Decrease Increase 
Figure 1: Translational regulation in mouse embryonic stem cells 
A) mES cells were induced to differentiate by removal of the pluripotency factor 
Nanog. B) Snapshots from heat map movies of400 genes with the most significant 
changes in protein level on Day 5 show discordant mRNA and protein level changes 
by histone acetylation (HIS), chromatin-bound RNA Polymerase II (POL), mRNA 
levels (RNA) and protein levels (PRO), indicative of translational control. 
Figure from Lu et al. 2009 
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stability is controlled is accomplished by varying the length of the poly(A) tail, with 
longer (80-500 A) tails correlating with increased translation and shorter (20-50 As) tails 
with silencing. In eukaryotes, translational initiation is a complex step that is dependent 
on the 5' cap of the messenger RNA and its interaction with many initiation factors (elFs) 
that facilitate recruitment and loading of the 40S ribosomal subunit (Kervestin and 
Amrani 2004). Translational initiation is also largely dependent on additional layers of 
control and regulation by phosphorylation. For example, the phosphorylation of proteins 
that bind to the initiation factor eIF4E facilitates the circularization of the mRNA that is 
necessary for the recruitment of ribosomal subunits and ultimately for protein synthesis 
(Sonenberg and Dever 2003). Because of the complexity of these mechanisms, 
translational control proteins can act at many different stages to regulate steady state 
protein levels. Control of 5'cap stability or poly(A) tail length affects mRNA decay rates 
and consequently steady-state mRNA levels. Protein binding to 5'cap components or 
interference with the poly(A)-binding protein (PABP)-eIF4E interaction that is necessary 
for translational initiation can block protein synthesis. Interference with proteins that 
mediate translational elongation allows the formation of the ribosome and loading of the 
mRNA but prevents the formation of peptide bonds or release of the nascent polypeptide. 
Despite the high energetic cost to the cell, these mechanisms of translational 
control are crucial to many biological processes. First, asymmetric localization of 
proteins is fundamental to stem cell biology as it allows a single cell to produce one 
daughter cell that will remain pluripotent and another daughter cell that will undergo 
multiple fate decisions along the way to terminal differentiation. Second, protein 
gradients that are created by translational regulation allow early axis formation during 
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embryogenesis that lay the foundations for the spatial and temporal gene regulation that 
direct a single fertilized egg to develop into an adult organism. Third, translational 
control allows the cell to respond rapidly to changes in its environment. While 
transcription factors require nuclear translocation, DNA sequence recognition, mRNA 
transcription, and localization, translational regulators can be poised on pre-localized 
mRNA and act as a molecular "switch" that rapidly activates or inactivates gene 
expression at the appropriate developmental time point. Fourth, translational regulation 
allows maternal control of embryonic development. Lastly, translational regulation 
allows for the control of either single mRNAs or entire classes of mRNAs by a small 
number of proteins. Some translational regulators contain a high fidelity binding 
sequence and are responsible for the activation or repression of a single protein. Other 
regulators bind to functionally-related or tissue-specific classes of mRNAs, while others 
regulate the translation of proteins such as transcription factors that can have widespread 
effects on the genome. Cells expend a considerable amount of energy to transcribe and 
localize mRNAs that may be translationally dormant, but the advantages of having such 
precise control over protein expression appear to far outweigh the costs. 
Pumilio Is a Well-Characterized Translational Repressor in Drosophila 
During Drosophila embryogenesis, translational regulation is essential to establish 
and maintain protein gradients that direct patterning of the body axes. Since zygotic gene 
transcription does not begin in the fly embryo until mitotic cycle 10 (Foe, Odell and 
Edgar 1993), the embryo relies on maternally provided mRNA for its early patterning 
cues. One classic example is the spatial regulation of hunchback (hb) mRNA. Although 
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maternal hb mRNA transcripts are uniformly distributed throughout the embryo (Tautz 
and Pfeifle 1989), Hunchback protein is restricted to the anterior half of the embryo 
where it directs head and thorax development and represses abdominal development 
(Wharton and Struhl 1991, Gavis 2001). This translational repression is mediated by a 
complex of three proteins - Pumilio (Pum), Nanos (Nos), and Brain Tumor (Brat) (Figure 
2B). 
Pumilio, the founding member of the PUF (for Pumilio and FBF [fem-3 binding 
factor]) family of proteins, was first identified as a maternal effect mutant required for 
embryonic patterning in Drosophila (Lehmann and Nusslein-Volhard 1987, Lehmann 
and Nusslein-Volhard 1991). Null mutations of Pumilio (Latin for "dwarf") results in 
small inviable embryos that do not form an abdominal segment (Ryder 2011). Pumilio 
contains a Pumilio-Homology Domain (Pum-HD) in its C-terminus that directly binds the 
Nanos Response Element (NRE), a conserved 32 nucleotide sequences in the 3' 
untranslated region (UTR) of hb mRNA (Figure 2A) (Murata and Wharton 1995, 
Zamore, Williamson and Lehmann 1997). The Pum-HD consists of eight tandem 
imperfect repeats of 36 amino acids and conserved N- and C- terminal flanking regions 
(Figure 2A). The PUM-HD is necessary and sufficient to mediate RNA binding and 
translational repression, and can rescue the phenotype of pum loss-of-function fly 
embryos (Wharton et al. 1998). The crystal structure of fly and human Pum-HD bound 
to its cognate NRE has reveals a curved structure in which each of the eight repeats in the 
concave surface forms an alpha helical motif that directly contacts one RNA base in the 
NRE of its target mRNA (Figure 2D, Edwards et al. 2001, Wang et al. 2001). This Pum-
RNA interaction, in association with the proteins Nanos (Nos) and Brain Tumor (Brat) in 
17 




head and thorax abdomen 
Figure 2: Structure and function of Pumilio proteins 
A) The C-terminal Pumilio-Homology Domain (Pum-HD) contains eight repeats of 36 
amino acids (black boxes) that bind directly to mRNA. B) Puniilio (orange), Brat (red), 
and Nanos (green) translationally repress hunchback mRNA in the posterior region of 
the Drosophila embryo to restrict Hunchback protein expression to the anterior pole. 
C) The consensus binding sequence of the Nanos Response Element (NRE). D) The 
crystal structure of the Pum-HD reveals a curved domain that directly binds mRNAs 
on its concave surface and proteins on its convex surface. Figures modified from 
Gavis (2001), Morris et al. (2008), Wang, Zamore and Hall (2001). 
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Drosophila, mediates the translational repression of hb mRNA through a mechanism 
which has yet to be defined (Barker et al. 1992, Murata and Wharton 1995), but likely 
acts through both poly(A)-dependent (Wreden et al. 1997, Wharton et al. 1998, 
Goldstrohm et al. 2006) and poly(A)-independent pathways (Chagnovich and Lehmann 
2001). Interestingly, Pum and Brat are also uniformly expressed throughout the 
Drosophila embryo (Macdonald 1992) and thus cannot confer the spatial specificity of hb 
mRNA repression; this role is provided by the posterior-specific protein Nanos (Barker et 
al. 1992). 
Recent studies have demonstrated that Pumilio proteins can both activate and 
repress the translation of their targets. In C. elegans, Fem-3 mRNA Binding Factor 1 
(FBF-1) can act as a molecular "switch" that can either increase or decrease gld-1 
expression during germline development (Suh et al. 2009) and mediate translational 
activation in olfactory sensory neurons (Kaye et al. 2009). Similarly in T. brucei, PUF 
RNA Binding Protien 9 (PUF9) has been shown to regulate the cell cycle by increasing 
transcript levels of several key regulatory proteins (Archer et al. 2009). How a single 
protein can both increase and decrease target mRNA translation remains a mystery, and 
whether all or only some Pumilio proteins have this ability remains completely unknown. 
Pumilio Proteins Bind Directly to RNA 
The Pumilio consensus RNA binding sequence is UGUAHAUA (where H is 
A/C/U), with a four nucleotide core UGUR (where R is a purine) that is sufficient for 
binding (Figure 2C) (Morris et al. 2008). However, translational regulation by Pumilio is 
much more complicated than simple recognition of an eight nucleotide motif. Following 
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publication of the crystal structure of Drosophila Pumilio, several groups have shown that 
Pumilio does not bind to every mRNA with an NRE, and it has the capacity to bind to 
mRNAs without any identifiable NRE (Ryder 2011). One explanation of these findings 
is that the Pum binding sequences need not be linear; some mRNAs have a secondary 
structure that forms a loop of extra nucleotides in the middle of an NRE that are 
functionally "invisible" to Pumilio, as the eight nucleotide motif is formed instead by the 
flanking sequences (Wang et al. 2009). In this manner the Pumilio binding sequence can 
actually be longer than eight nucleotides, although the protein still directly contacts only 
eight RNA bases. Drosophila Pumilio recognizes two separate sequences in the NRE of 
target mRNAs termed Box A and Box B, with the greatest binding affinity for Box B 
sequences (Gupta et al. 2009). Lu and Hall discovered that position five of the PUM1 
and PUM2 NRE can be degenerate, allowing these proteins to form four slightly different 
structural contacts with four different mRNA targets; they hypothesize that the manner by 
which Pumilio proteins bind their targets can have functional implications (Lu and Hall 
2011). 
Another layer of complexity is that the in vitro mRNA targets of Pumilio do not 
necessarily reflect the in vivo targets of the protein. Pumilio-RNA binding likely depends 
not only on the NRE sequence within the mRNA, but also on the protein binding partners 
present in the complex. The curved Pum-HD domain binds to mRNA on its highly basic 
concave surface and to protein partners on its acidic convex surface (Figure 2D) 
(Edwards et al. 2001, Wang et al. 2001). While the exact effect of this binding on the 
recognition of mRNA targets remains unknown, it is likely that different protein partners 
confer different mRNA binding affinities to the Pum-HD. In human germ cells, for 
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example, PUM2 binds a different subset of mRNAs when it is bound to the protein 
Deleted in Azoospermia-Like (DAZL) than when it is bound to BOULE (BOL) (Urano, 
Fox and Reijo Pera 2005). These interactions may represent a mechanism by which a 
global translational repressor can fine-tune its regulatory effects depending on the tissue-
type, gene expression profile, or developmental stage of a particular organism. Such 
protein-protein interactions may also lend insight into the mechanisms by which Pumilio 
proteins regulate their targets. For example, Drosophila Pumilio is bound to Brain tumor 
(Brat), which recruits the translational inhibitor d4EHP that can outcompete eIF4E for 
binding to the 5'cap (Cho et al. 2005). Yeast Puf 6 represses translation by inhibition of 
the translation initiation factor eIF5B (Deng, Singer and Gu 2008). Likewise, several 
Pumilio proteins decrease mRNA stability by recruitment of the Ccr4-Pop2-NOT 
deadenylase complex (Quenault et al. 2011). 
A third level of complexity of the Pumilio-RNA interaction is that Pumilio proteins 
have recently been shown to interact with the microRNA (miRNA) regulatory system. 
miRNAs are short (-22 nucleotide) non-coding RNAs that bind to complementary 
sequences on target mRNAs as part of the RNA-induced silencing complex (RISC) that 
mediates post-transcriptional gene silencing. miRNAs perform crucial regulatory roles in 
diverse organisms, and have been estimated to control the gene expression of up to thirty 
percent of all protein-coding mammalian genes (Ebert and Sharp 2010). In 2010, Kedde 
et al. showed that PUM1 binding induces a local conformational change in the secondary 
structure ofp27 mRNA, exposing miR-221/mER-222 binding sites that lead to the 
recruitment of RISC and the subsequent mi-RNA dependent repression of p27 (Kedde et 
al. 2010). They also observed that phosphorylation of PUM 1 enhances its RNA-binding 
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ability (Kedde et al. 2010). Puml and Pum2 also bind to many target mRNAs 
representing diverse cellular pathways. Together, these data suggest that the regulation 
of Pumilio proteins in vivo is extremely complex and that there are many facets of its 
function that have yet to be unraveled. 
Evolutionary and Functional Conservation of Pumilio proteins 
The evolutionary conservation of Pumilio is striking. To date, Pumilio 
homologues have been identified and characterized in yeast (Garcfa-Rodriguez, Gay and 
Pon 2007), protozoa (Droll et al. 2010), fungus (Zhang et al. 2012), plant (Abbasi et al. 
2010, Tam et al. 2010), flatworm (Koziol, Marin and Castillo 2008, Salvetti et al. 2005), 
roundworm (Nolde et al. 2007), frog (Nakahata et al. 2001, Ota, Kotani and Yamashita 
2011), fish (Zhao et al. 2012, Kuo et al. 2009), chicken (Lee et al. 2008), mouse (White, 
Moore-Jarrett and Ruley 2001, Spassov and Jurecic 2003, Xu et al. 2007), rat (Vessey et 
al. 2006), and human (Spassov and Jurecic 2002). The number of PUF homologues in 
each species varies considerably, from one in Drosophila, two in humans, six in yeast, 
nine in worms, to twenty-five in Arabidopsis (Abbasi, Park and Choi 2011). Some 
homologues have redundant functions while others seem to have tissue-specific functions 
that only partially overlap (Quenault et al. 2011). Some proteins embody duel regulatory 
functions such as FBF, which can repress translation in the germline while activating 
translation in sensory neurons (Kaye et al. 2009). While the N-terminus of PUF proteins 
varies considerably, the RNA-binding C-terminal Pum-HD retains 80% identity between 
fly and human (Zamore et al. 1997) and nearly 98% identity among vertebrate 
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Figure 3: Evolutionary Conservation of the Pumilio-Homology Domain (Pum-
HD) Figure from (Spassov and Jurecic 2002) 
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an RNA-binding motif almost identical to that found in flies, which can bind target 
mRNAs with equal affinity (Jenkins, Baker-Wilding and Edwards 2009). NRE 
sequences to which Pumilio proteins bind are present in thousands of diverse mRNAs 
(Morris et al. 2008) from yeast to humans. Pumilio proteins thus have the potential to 
regulate a wide array of developmental processes through translational repression of 
specific mRNAs in many species. PUF proteins are so structurally conserved that human 
Pumilio can repress Drosophila mRNA targets (Fox, Urano and Reijo Pera 2005) and C. 
elegans FBF can mediate translational repression in yeast (Chritton and Wickens 2010). 
In addition to its function in embryonic patterning during early Drosophila 
development (Nusslein-Volhard, Frohnhofer and Lehmann 1987), PUF proteins are 
involved in germline stem cell development in the Drosophila ovary (Lin and Spradling 
1997, Forbes and Lehmann 1998), regulation of the sperm/oocyte switch and germline 
maintenance in C. elegans (Zhang et al. 1997, Kraemer et al. 1999, Lamont et al. 2004), 
mitochondrial function in S. cerevisiae (Garcia-Rodriguez et al. 2007, Saint-Georges et 
al. 2008), cell cycle regulation (Seay et al. 2006, Traven et al. 2010) and long-term 
memory and neuronal excitability in Drosophila (Dubnau et al. 2003, Muraro et al. 2008, 
Menon et al. 2004). Xenopus Pumilio is required for the translational regulation of 
Cyclin Bl during oocyte maturation (Nakahata et al. 2003), indicating that the structure, 
function, and even some specific molecular targets of this protein family are conserved 
across species. 
Pumilio proteins have also shown a remarkable diversity in the posttranscriptional 
processes that they regulate. In various organisms, Pum proteins have been shown to be 
involved in RNA decay, cytoplasmic deadenylation, RNA transport, rRNA processing 
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and ribosome biogenesis, mitochondrial motility, translational initiation, and translational 
elongation. Pumilio can simultaneously control the translation of many targets by 
mediating the decay of the translational initiation factor eIF-4E in various tissues, as has 
been shown for Drosophila Pumilio (Menon et al. 2004) and mammalian Pum2 (Vessey 
et al. 2010) during neuronal development. Similarly, some Pumilio homologues 
physically bind to the 7-methyl guanosine cap and outcompete eIF-4E binding that is 
necessary for formation of the translational initiation complex (Cao, Padmanabhan and 
Richter 2010). Pumilio proteins have been shown to play a role in mRNA localization 
which can mediate both the spatial and temporal control of gene expression (Vessey et al. 
2006, Saint-Georges et al. 2008, Eliyahu et al. 2010) and in the inhibition of translational 
elongation through the recruitment of Argonaute proteins and eEFl A (Friend et al. 2012). 
Interestingly, this PUF-Ago-eEFIA interaction is thought to block translational 
elongation approximately 100-140 nucleotides into the open reading frame in C. elegans 
and humans (Friend et al. 2012) and may represent a common pathway between Pum-
mediated translational repression and Argonaute/RISC complex-mediated mRNA 
stability and translation. 
Stem Cell Maintenance: An Ancestral Function of Pumilio Proteins 
Although Pumilio is involved in diverse cellular processes, recent work has 
suggested that the ancestral function of Pumilio lies in stem cell proliferation and self-
renewal (Parisi and Lin 2000, Wickens et al. 2002). Several lines of evidence support 
this hypothesis. First, Pumilio is required for the asymmetric division of stem cells in 
several model systems. Asymmetric division is a fundamental mechanism of stem cell 
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maintenance that allows one daughter cell to remain a pluripotent, self-renewing stem 
cell while the other daughter cell differentiates into a cell with more restricted potential. 
In the Drosophila ovary, loss of Pumilio function results in symmetric, rather than 
asymmetric division of germline stem cells that leads to the differentiation and depletion 
of the stem cell pool (Figure 4) (Lin and Spradling 1997, Parisi and Lin 1999). A similar 
phenotype is observed in Nanos mutants, and Pum-Nos double mutants (Wang and Lin 
2004). In addition, the C. elegans Pum homologue FBF promotes germline stem cell 
proliferation and inhibits differentiation through the translational repression of gld-2 
mRNA (Crittenden et al. 2002). PufA, a Pumilio homologue in Dyctiostelium, sustains 
growth and inhibits differentiation (Souza, da Silva and Kuspa 1999), while in Planaria, 
knockdown of DjPum dramatically reduces the number of totipotent stem cells (Salvetti 
et al. 2005). Even in plants, Pumilio homologues are involved in the regulation of 
mRNAs involved in shoot stem cell maintenance (Francischini and Quaggio 2009). 
These data indicate a functionally conserved role of PUF proteins in stem cell 
maintenance and proliferation that may extend to mammalian systems. However, the 
function of Pumilio in vertebrate systems is not well understood. Xu et al. have 
demonstrated that Pumilio 2 loss-of-function produces mice with significantly smaller 
testes but no detectable differences in fertility or viability (Xu et al. 2007). There are two 
homologues of Pumilio in humans, PUM1 and PUM2 (Spassov and Jurecic 2002). Their 
associated mRNA transcripts have a widespread and overlapping pattern of expression in 
human tissues and are both expressed in human embryonic stem cells (Jaruzelska et al. 






Figure 4: Pumilio is required for the self-renewing asymmetric divisions of 
germline stem cells during Drosophila oogenesis 
A) Wild type ovarioles, with two germline stem cells at the apical tip (g) that have 
undergone asymmetric divisions to produce a string of developing egg chambers. 
B) Pumilio loss-of-function mutant, with only two mature egg chambers and a 
rudimentary germarium (g). 
Figure from Parisi and Lin (1999) 
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its interaction with the DAZ/DAZL protein complex that mediates primordial germ cell 
differentiation (Moore et al. 2003). PUM2 is also expressed in mesenchymal stem cells 
and in a subset of adipose-derived stem cells, where it is associated with mRNAs 
involved in controlling cell proliferation (Shigunov et al. 2012). 
These studies shed light on the role of Pumilio proteins in mammalian systems, 
but there are many remaining unanswered questions. What is the function of Puml in 
mammals? Is Puml compensating for the loss of Pum2 in the recent work by Xu et al.? 
Do Puml and Pum2 bind the same mRNAs in mammalian cell systems, or are these 
species and/or cell-type specific? Do Puml and Pum2 bind to the same protein partners? 
These fundamental questions of Pumilio protein function in vertebrate systems are central 
to our understanding of translational control in higher eukaryotes, and may lend insight 
into the mechanisms of stem cell self-renewal and differentiation. This thesis 
investigates the hypothesis that Pumilio proteins play an important role in embryonic 
stem cells and during early mammalian development by translationally repressing genes 
through the destabilization or translational inhibition of their mRNA transcripts. In this 
study I show that mammalian Puml and Pum2 proteins are indeed essential for 
development, as the loss of both proteins results in early embryonic lethality. The 
mechanisms of Pumilio function in mouse embryonic stem cells are further explored by 
identification and characterization of its interacting mRNAs and proteins. It is our hope 
that the answers to these basic questions about mammalian Pumilio proteins will lend 
insight into the molecular mechanisms of translation control in stem cell self-renewal and 
differentiation, and may one day help us harness the enormous clinical potential of 
embryonic stem cells. 
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Chapter 2 




The process by which a single fertilized egg gives rise to a complex adult 
organism has been studied extensively over the past century. Upon fertilization of the 
oocyte, the zygote undergoes several rounds of cleavage divisions as it travels to the 
uterus (Figure 5A). These divisions do not increase the total size of the embryo, but 
reduce the cytoplasmic volume of each cell as it forms a 2-cell, 4-cell, 8-cell, and 16-cell 
embryo (Gilbert 2000). By the 16-cell stage, the embryo has formed a compact ball of 
cells termed a morula and has already started to establish the anterior-posterior axis that 
lays the groundwork for the body plan of the entire organism (Beddington and Robertson 
1999). The first asymmetry is thought to occur as the morula divides (Johnson, Maro and 
Takeichi 1986); cells on the outer surface become polarized and ultimately will form the 
trophectoderm that develops into the placenta, while the inner apolar cells form the inner 
cell mass that gives rise to all tissues of the body. By three days post fertilization (e3.0) 
the embryo develops into a blastocyst when cavitation of the morula results in the 
development of a fluid-filled blastocoel that physically separates the outer trophectoderm 
from the inner cell mass (Figure 5B). The blastocyst is composed of approximately 100 
cells, 75 percent of which will form placental and supporting structures, and 25 percent of 
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Figure 5: Murine Embryogenesis 
A) Development from ovulation (eO) to implantation of the blastocyst (e4.5) 
B) Embryonic development from fertilization to birth Images © 2001 Terese Winslow 
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By e4.5, the blastocysts hatches from the outer zona pellucida and implants into 
the uterine wall (Figure 5A). Upon implantation, the blastocyst elongates and continues 
to differentiate into three distinct cell types: the outer trophoblast cells that give rise to 
supporting extraembryonic tissue and the placenta, the inner epiblast cells that are 
derived from the inner cell mass and will give rise to all embryonic tissues, and the 
primitive endoderm (or hypoblast) which gives rise to extraembryonic membranes 
(Gilbert 2000). At e6.5 the embryo undergoes a critical process known as gastrulation, 
during which the epiblast cells undergo involution and begin to differentiate into the three 
distinct germ layers: endoderm, mesoderm, and ectoderm (Figure 5B). Much work has 
been focused on this critical stage of development, but we are only beginning to 
understand the signaling cascades, cell division, cell migration, cell specialization, and 
programmed cell death that must be precisely coordinated for gastrulation to occur and 
development to proceed. Because it is technically difficult to study the signals and genes 
involved in these processes in vivo, most of our current understanding of the molecular 
and genetic basis for in vivo embryogenesis and differentiation has come from in vitro 
studies of embryonic stem cells. 
Embryonic stem cells are derived from the inner cell mass of the blastocyst. The 
first embryonic stem cell lines were derived from mouse embryos in 1981 (Evans and 
Kaufman 1981, Martin 1981) by culturing inner cell mass cells on a layer of fibroblasts 
that had been treated with the mitotic inhibitor mitomycin-c. Single cells were expanded 
into clones that were found to be capable of both self-renewal and differentiation into 
various tissue types in teratomas (Martin 1981). Although some have argued that 
embryonic stem cells are an "in vitro phenomenon" because the immortality of ES cells 
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only occurs in cell culture (Marshak, Gardner and Gottlieb 2001), they are a valuable tool 
that allows us a window into the underlying biology of pluripotent cells. ES cells in 
culture are able to give rise to tissues derived from all three germ layers, but unlike the 
inner cell mass cells of the early embryo, ES cells are unable to give rise to a complete 
organism because they lack signals from the trophectodermal and supporting cells, and 
they lack the three-dimensional environment and niche signaling required for in vivo 
development (Marshak et al. 2001). Mouse embryonic stem cells rely on the cytokine 
leukemia inhibitory factor (LIF) to remain undifferentiated in culture, while human cells 
rely on LIF-independent signaling pathways (Thomson et al. 1998). The cell cycle 
consists of DNA replication (S phase), a gap phase during which the cell grows and 
prepares to divide (G2), mitosis (M), and continued cell growth in preparation for the 
next round of replication (Gl). Mouse embryonic stem cells proceed rapidly through the 
cell cycle and progress near-continuously from S to M phases because they have almost 
no functional Gl and G2 gap phases (Ballabeni et al. 2011). 
Murine Pumilio Proteins 
The murine puml transcript, first cloned in 2003, encodes an 1189 amino acid 
long, 127 kilodalton (kDa) protein that contains a 361 amino acid Pum-HD in its C-
terminus. The murine pum2 transcript encodes an1066 amino acid, 114 kDa protein with 
a nearly identical Pum-HD domain in its C-terminus (Figure 3) (Spassov and Jurecic 
2002). puml and pum2 mRNA are expressed in embryonic stem cells (Jaruzelska et al., 
2003; Moore et al., 2003) as well as in many fetal tissues including ovary, testis, brain, 
liver, and heart (Moore et al. 2003) by northern blot and RT-PCR analysis, puml mRNA 
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is expressed in adult brain, heart, kidney, liver, lung, muscle, skin, intestine, spleen, 
stomach, testis, and thymis, while pum2 mRNA shows lower expressions in all adult 
tissues except the skin and thymus, and no detectable expression in the lung, spleen, and 
testis (Spassov and Jurecic 2003). 
Pum2-deficient ES cells were generated that contain a gene trap mutation between 
exon 10 and 11 (Pum2-XE772), which results in a truncated Pum2 protein that lacks the 
Pum-HD (Siemen et al. 2011). Depletion of Pum2 in ES cells by this method have no 
obvious defects in self-renewal or differentiation (Siemen et al. 2011). Depletion of 
Pum2 in mice results in smaller testes in males with no defects in fertility (Xu et al. 
2007), as well as subtle neurological defects in memory, nesting behavior, and seizure 
thresholds (Siemen et al. 2011). However, whether the truncated Pum2 protein is still 
able to bind to protein binding partners, or if it retains any of its Pum-HD-independent 
functions remains unknown. The reported Pum2-deficient mice have two normal gene 
copies of the other mammalian Pumilio homologue, Puml, which likely compensates for 
the loss of function of Pum2 and masks any phenotype resulting from the total absence of 
Pumilio proteins. The role of Puml in both embryonic stem cells and in mice is 
unknown. 
In this chapter, I report the generation of Puml - and Pum2- deficient ES cell lines 
and conditional knockout mice. Puml-/- and Puml-/-;Pum2+/- ES cells have a slower 
cell doubling time than wild type ES cells, but express pluripotency parkers and are 
capable of self-renewal. Puml-/- mice are viable but smaller than their littermates, have 
an increased incidence of ulcerative dermatitis, disorganized small intestinal villi, and a 
hunched appearance that worsens with age. Pum2-/- mice are viable and show no 
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obvious defects in gross or microscopic anatomy. Puml-/-;Pum2+/- are born but die 
shortly after birth, and Puml-/-;Pum2-/- double knockout animals are embryonic lethal 
between e8.5 and e9.5. Together, these data reveal an essential role of Pumilio proteins 
during early embryogenesis. 
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Results 
Puml and Pum2 are cytoplasmic in mouse embryonic stem cells 
To investigate the function of Puml and Pum2 in embryonic stem cells, I first 
determined their subcellular localization by cytoplasmic/nuclear fractionation and 
immunofluorescence experiments. Total, cytoplasmic, and nuclear fractions were 
prepared from cell lysate of CCE cells (Stem Cell Technologies) by differential 
centrifugation. Antibodies against glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and phosphorylated RNA Polymerase II (Pol II) were used as markers for the 
cytoplasmic and nuclear fractions, respectively. Western blots indicate that both Puml 
and Pum2 are predominantly cytoplasmic proteins in mES cells (Figure 6A). A small 
fraction of Puml may be nuclear, however this may represent Puml association with the 
nuclear membrane and not intrinsic nuclear localization. These data are confirmed by 
immunofluoresence staining of mES cells that reveal a diffusely cytoplasmic distribution 
of both Puml and Pum2 (Figure 6B, 6C). Puml is expressed in both dividing and non-
dividing cells, and appears to be particularly abundant around the nuclear periphery in 
some mitotic cells (Fig 6C; arrow). 
Puml-deficient mES cells grow slowly but are self-renewing andpluripotent 
Of the two mammalian Pumilio proteins, Puml is more widely expressed than 
Pum2 in adult and fetal tissues (Spassov and Jurecic 2003). To determine the function of 
these proteins in ES cells, I investigated the effects of Puml knockdown in ES cell 
cultures. Approximately 80 percent knockdown of Puml was achieved by transient 
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Figure 6: Subcellular localization of Puml and Pum2 
A) Total (Tot), cytoplasmic (cyto), and nuclear (nuc) mES lysate fractions B) 
Antibody specificity C) Puml and Pum2 are diffusely cytoplasmic and Puml is 
enriched in the nuclear periphery of some mitotic cells (arrow). 
36 
transfection of CCE mES cells with Puml -specific siRNA, and resulted in fewer cells 
present 48-hours post transfection compared to control transfections with scrambled 
siRNA (Figure 7), but no apparent differences in cellular morphology or differentiation. 
In light of the known role of Pumilio proteins in stem cell pathways, I next investigated if 
Puml-deficient cells are capable of differentiation. However, it was difficult to assess 
the long-term effects of knockdown during differentiation with these experimental 
approaches due to the transient nature of siRNA-mediated gene knockdown. To avoid 
these limitations and to explore a more biologically relevant model of Pumilio function, 
Puml conditional knockout mice were generated in collaboration with the Gene 
Targeting and Transgenic Facility at the University of Connecticut Health Center. 
Conditional knockout Puml mice were generated by flanking exons 8 and 9 of 
the puml gene with LoxP sites in order to effectively target all splice variants (Figure 
14A). This strategy results in a truncated Puml protein of 448 amino acids that is 
upstream of the Pum-HD, with the last 31 amino acids out of reading frame. Puml 
flox/+ mice were crossed and embryonic stem cell lines were derived from e3.5 embryos 
by culturing blastocysts on mouse embryonic fibroblast (MEF) feeder cells in the 
presence of LIF (Figure 8A). Wild type, Puml Flox/+, and Puml Flox/Flox embryonic 
stem cell lines were derived, transfected transiently with a pBabe-Puro-Cre plasmid 
expressing Cre recombinase, and selected in media containing puromycin to generate 
wild type, Puml +/-, and Puml -/- cell lines, respectively (Figure 8B). Knockout of wild 
type Puml in these cell lines was confirmed by genotyping (Figure 8B), quantitative RT-
PCR (Figure 8C), and western blot analysis (Figure 8D), indicating that a truncated 
protein is not stably expressed. 
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Figure 7:Puml-knockdown results in fewer mES cells 
Images of CCE mouse ES cells 48 hours after transfection with scrambled, non-
silencing siRNA (left) or Puml-specific siRNA (right). Puml knockdown efficiency 
was quantified by western blot analysis for non-silencing siRNA (siNS) and Puml-
siRNA (siPuml) with GAPDH as a loading control (lower panel). 
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Figure 8: Derivation of Puml-Deficient ES Cell Lines 
A) Blastocysts were isolated from e3.5 uteri and plated on MEF cells in the presence of 
LIF to derive new ES cell lines. B) Genotyping confirmed the loss of the Puml floxed 
allele after Cre-mediated excision. C) qRT-PCR and D) western blot analysis 
confirmed the absence of any Puml in KO cells. E) Pum2 is upregulated in Puml KO 
cells, while Oct4 and Nanog expression are unchanged. 
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Puml -/- ES cells are viable but grow more slowly than Puml +/- and wild type 
cell lines (Figure 9A). When equal numbers of wild type, Puml+/-, and Puml-/- were 
plated and grown under standard ES conditions, 50 percent fewer Puml-/- cells were 
recovered after 48 hours in culture by FACS analysis (Figure 9B). To further 
characterize the temporal progression of these growth deficits, low density WT, Puml +/-
, and Puml-/- cells were plated and quantified every 12 hours until the cultures reached 
confluency. Puml-/- cells were eventually able to achieve the same growth rate as 
control cells (slope of the growth curve in Figure 10), but due to a lag in growth at lower 
densities, the total number of Puml -/- cells was 50% percent lower than the wild type or 
heterozygous control cell lines at any given time point (Figure 10). After 84 hours in 
culture, all cell lines reached confluency with a corresponding decrease in the growth rate 
(Figure 10). To determine if the observed reduction in cell number could be attributed to 
decreased proliferation and/or increased cell death, I quantified the percentage of dividing 
cells by EdU incorporation assays and quantified the number of apoptotic cells by 
Annexin V and cleaved caspase-3 staining. Cells were incubated in the presence of EdU, 
a nucleoside analog of thymidine that is incorporated in dividing cells, and quantified by 
FACS analysis to estimate the percentage of cells in Gl, S, and G2/M phases of the cell 
cycle. 8.6% of wild type cells were in Gl phase, 77.1% in S and 12.8% in G2/M. Puml 
floxed cells showed 10.0% in Gl, 74.0% in S, and 14.5% in G2/M. 9.62% of Puml-/-
celis were in Gl, 74.8% in S, and 14.1% in G2/M (Figure 11 A, 1 IB). Annexin V, an 
early marker of apoptosis, and propidium iodide, a marker for necrotic cells, were 
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Figure 9: Puml -/- mES Cells are viable but grow more slowly than Puml+/- cells 
A) Images of Puml+/- mES ceils (upper panel) and Puml-/- cells (lower panel) after 2, 
3, and 4 days of plating identical cell numbers on MEF feeder cells. 
B) Cell numbers were quantified after 48 hours of passage by FACS analysis, 
normalized to a known quantity of beads added to culture dishes for normalization. 
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Figure 10: Cell doubling time of WT, Puml+/-, and Puml-/- ES cells 
0.2 x 106 WT (blue), Puml+/- (green), and Puml-/- (red) ES cells were plated on 
gelatin-coated tissue-culture plates and counted by hemocytometer at 0,12,24, 36, 48, 
60, 72, and 84 hours after passage. Error bars represent standard error of the mean. 
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Cell Cycle Analysis by EdU Incorporation 
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Figure 11: Ceil proliferation is not impaired in Puml-/- ES cells 
A) Cells were incubated in the presence of EdU (Click-iT EdU Alexa-Fluor 647) and 
stained with propidium iodide (PI), then analyzed by FACS for expression of Alexa 
Fluor 647 (y axis) and PI (x axis). B) Percentages of cells in Gl, S, and G2/M phases 
were quantified based on an analysis of the FACS data with FloJo software. 
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analysis. Puml-/- cells demonstrated a 5.7 percent increase in necrotic cells when 
compared to Puml floxed cells (Figure 12A). Moreover, the apoptotic cell marker 
Cleaved-Caspase-3 is upregulated two-fold in both Puml-/- and Pum2-/- ES cells, and 
4.5-fold in Pum 1 -/-;Pum2+/- cells (Figure 12B, 12C). Overall, these data suggest that 
Pum-deficient ES cells are able to proliferate normally but have significantly increased 
rates of apoptosis which contributes to a slower growth rate than wild type cells. 
To assess the functional capabilities of Puml-/- ES cells I investigated whether 
these cells were capable of self-renewal and differentiation into the three germ layers. 
Pluripotency markers Nanog and Oct4 are expressed in Puml-/- cells (Figure 8E), and the 
cell lines formed ES-like raised colonies after repeated passages (>20). To determine if 
differentiation is impaired in these cells I generated embryoid bodies by removal of LIF 
and culture on non-adherent tissue culture plates (Figure 13B), followed by quantitative 
RT-PCR for markers of endodermal, mesodermal, and ectodermal lineages. Expression 
of the pluripotency marker Nanog decreased over the course of differentiation as 
expected, while endoderm markers Foxa2 and Sox 17, mesoderm markers goosecoid and 
Mixll, and ectoderm markers FGF5 and Mashl all increased expression at the 
appropriate developmental time point (Figure 13A), suggesting that Puml-/- cells are 
capable of forming all three germ layers. In light of these data demonstrating the 
viability and pluripotency of Puml-deficient ES cells, I next sought to investigate the 
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Figure 12: Puml-deficient ES cells have an increased rate of apoptosis 
A) ES cells were incubated with annexin V conjugated to Alexa Fluor 488 (Invitrogen) 
and propidium iodide, and analyzed by FACS. Lower left quadrant = viable cells, 
lower right quadrant = apoptotic cells, upper right quadrant = necrotic cells. B) Total 
cell lysate from Puml floxed, Puml KO, Pum2 KO, and Puml-/-;Pum2+/- ES cells 
were separated by SDS-PAGE, probed with anti-CIeaved Caspase-3 antibody, and 
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Figure 13: Embryoid body formation and lineage marker expression analysis 
A) qRT-PCR was conducted on RNA purified from embryoid bodies after the 
indicated time points. B) ES cell culture on low-adherence tissue culture plates in the 
absence of LIF resulted in the formation of embryoid bodies. 
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Puml -/- mice are viable to adulthood but are smaller than their wild type littermates 
To generate global Puml-/- mice, Puml flox/+ mice were bred with Ella-Cre 
mice that express Cre recombinase under the control of the adenovirus Ella promoter that 
is expressed in pre-implantation early mouse embryos. Puml +/- mice were bred to 
generate WT, Puml +/-, and Puml-/- offspring, and the efficiency of Cre-mediated 
recombination of the floxed Puml allele was confirmed by genotyping. Of 244 pups, 68 
(28%) were wild type, 142 (58%) were heterozygous, and 34 (14%) were Puml-/-
(Figure 14B). These data indicate that Puml-/- pups are viable but that loss-of-function 
confers a survival disadvantage as indicated by the significantly lower Mendelian ratio of 
mutant offspring. Male and female Puml-/- mice were smaller than their heterozygous 
and wild type littermates at all time points observed (Figure 15), with an average weight 
35% less than wild type at 28 dpp. Liver, kidney, spleen, heart, lung, stomach, intestine, 
testis, uterus, and notably, brain weights were all significantly less in Puml -/- mice 
(Figure 16A). When normalized to total body weight, most organs were proportionately 
smaller except the testis, kidney, spleen, and heart, which were disproportionately smaller 
in Puml-/- mice than in Puml+/- or wild type littermates (Figure 16B). To determine if 
there are any age-induced effects of Puml knockout, a cohort of Puml-/- mice were aged 
with wild type and heterozygous littermate controls. All but one Puml-/- mouse was 
afflicted with ulcerative dermatitis, a progressive and hereditary skin disorder that is 
common in C57BL/6 mice, and had to be euthanized before completion of the 
experiment. At eleven months, the remaining Puml -/- mouse weighed 43% less thai its 
wildtype littermate, had very little body fat, and had a prominent hunched appearance 
that became progressively worse with age (Figure 17A). 
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Figure 14: Generation of Puml knockout mice 
A) Exons 8 and 9 of puml were flanked with LoxP sites in the Puml KO strategy. 
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Figure 15: Puml-/- mice are smaller than Puml+/- and WT littermates 
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Figure 16: Puml-/- mice have smaller organs than Puml+/- and WT littennates 
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The incidence of ulcerative dermatitis was assessed by Kaplan-Meier survival curve 
analysis and showed a highly significant difference between Puml-/- mice vs. littennates. 
At 11 weeks approximately 20% of Puml-/- mice have ulcerative dermatitis compared to 
0% of wild type mice, and by 24 weeks almost 80% of Puml-/- mice have ulcerative 
dermatitis compared to 5% of wild type littermates (Figure 17B). 
In order to fully characterize the tissue-specific phenotypes of Puml -/- mice a 
comprehensive phenotypic analysis was conducted in collaboration with the Yale Mouse 
Research Pathology Department. Four eight-week old wild type mice (two males and 
two females) were compared to four Puml-/- mice (two males and females) and were 
assessed for gross and microanatomical defects. Hematoxylin and eosin staining of testis 
sections revealed degenerate cells in the epididymis of male Puml -/- mice (Chen et al. 
2012), and staining of the small intestine revealed blunted, disorganized villi in the 
duodenum of Puml-/- mice. Since I hypothesized that poor intestinal absorption might 
partially explain the smaller size of the Puml-/- mice, I chose to concentrate on the 
histological defects in the duodenum, jejunum, and ileum. While all regions appeared 
more disorganized in the Puml-/- mouse, as evidenced by portions of multiple villi 
visible in different planes of sectioning (Figure 18A) and planes of section with no 
detectable villus (Figure 18 A, arrows), there were no significant differences in Ki67 
staining as a marker of proliferation (Figure 18B), or in the villus length, crypt length, or 
villus:crypt ratio between wild type and Puml-/- mice (Figure 18C). 
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Figure 17: Aged Puml-/- mice are smaller, have a prominent hunched 
appearance, and have an increased incidence of ulcerative dermatitis 
A) Phenotype and weight of 11-month-old littermates. 
B) Kaplan-Meier survival plot of the relative risk of ulcerative dermatitis in WT (blue), 






gOOjyn Puml KO - Duodenum WT - duodenum 
0 
Duodenum Jejunum Ileum 
V C R V C R V C R 
WT 3.62 .52 14 2.20 .55 .25 1.21 .42 .35 
Puml KO 3.47 .45 13 2.13 .63 .29 1.22 .40 .33 
Figure 18: Puml-/- mice have blunted, disorganized villi in the small intestine 
A) Hematoxylin and eosin (H&E) staining and Ki67 staining (B) of duodenal sections 
from WT and Puml-/- mice. Arrows in A indicate planes of section with no detectable 
villus. C) V = villus length, C = crypt length, R = ratio of villus:crypt length in the 
duodenum, jejunum, and ileum of WT (n = 4) vs Puml-/- (n = 4) mice. Images by 
Carmen Booth, Yale Mouse Research Pathology. 
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Puml and Pum2 are partially functionally redundant 
The high level of similarity between the Pum-HD domains of Puml and Pum2 
(91% identity and 97% similarity) (Spassov and Jurecic 2003) suggests that these two 
proteins may be functionally redundant. To address this possibility Pum2 conditional 
knockout mice were generated in collaboration with the Gene Targeting and Transgenic 
Facility at the University of Connecticut Health Center. Exon 3 of the pumilio 2 gene 
was flanked with LoxP sites in a strategy that after Cre excision would produce a 40 
amino acid protein with the last 23 amino acids out-of-frame (Figure 19A). Pum2 Flox/+ 
mice were mated with Ella-Cre mice as previously described to generate global Pum2 +/-
mice. Cre excision was confirmed by genotyping, and Pum2+/- were mated to generate 
wild type, Pum2+/-, and Pum2-/- mice. Of 161 offspring, 42 (26%) were wild type, 76 
(47%) were Pum2 +/-, and 43 (27%) were Pum2 -/- (Figure 19B). Unlike Puml-/- mice, 
there were no significant differences between the expected and observed Mendelian 
ratios of genotypes (Figure 19B), and no significant differences in body weight between 
male or female wild type and Pum2 -/- mice at all time points assessed (Figure 20). 
These results indicate that mice lacking Puml are viable but smaller, and mice 
without Pum2 are viable and phenotypically normal. I next sought to determine whether 
ES cells were viable with only one of the four Pumilio alleles (Puml+/-; Pum2-/- and 
Puml-/-; Pum2 +/-), or with all Pumilio proteins deleted (Puml-/-;Pum2-/-). I first 
derived Pum2-/- and Puml-/-;Pum2+/- mouse ES cell lines by isolating blastocysts from 
mated Puml Flox/+ mice and transfecting with Cre recombinase as has previously been 
described. Pum2-/- ES cells proliferate at the same rate as wild type cells, but Puml-/-
;Pum2+/- cells have a cell doubling time that is significantly delayed (Figure 21). 
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14.4g 14.1g 12.7g 
Avg wt. (28 dpp) 
pum2+/~ x pun?2 !+/-
wild type 42 26% 
pum2 +/- 76 47% 
pum2 -/- 43 27% 
Total 161 
Figure 19: Generation of Pum2 knockout mice 
A) Exon 3 ofpum2 was flanked with LoxP sites in the Pum2 KO strategy. 
B) Pum2 Pum2 +/-, and WT littermates at 28dpp and Mendelian ratios of crosses. 
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Figure 20: Pum2-/- mice weigh the same as Pum2+/- and WT littermates 
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Figure 21: Puml-/-; Pum2+/- ES cells have an increased cell doubling time 
0.2 x 106 WT (blue), Puml+/- (green), Puml-/- (red), Pum2 -/- (purple), and Puml-/-; 
Pum2 +/- (black) ES cells were plated on gelatin-coated tissue-culture plates and 
counted by hemocytometer at 0,12,24,36,48,60,72, and 84 hours after passage. 
Data represent mean ± SE of three independent experiments. 
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Repeated attempts to derive a Puml-/-; Pum2-/- ES cell line were unsuccessful, either 
from blastocysts of Puml+/-;Pum2+/- offspring or from Cre-mediated excision of 
Pumlflox/floX;Pum2f,ox/floxCell lines. These data suggest a partial functional redundancy of 
Puml and Pum2, leading me to investigate the minimal number of Pumilio alleles that 
are compatible with life. Because Puml-/- mice have decreased fertility (Chen et al. 
2012), I set up crosses between Puml+/-;Pum2+/- males and females that could generate 
nine possible genotypes (Figure 22A). Of 127 pups genotyped at ldpp, all genotypes 
were recovered except double knockout Puml-/-;Pum2-/- mice, leading to the conclusion 
that these pups are not viable at birth (Figure 22A, 22E). I observed less than the 
expected ratio of Puml-/-;Pum2+/- and Puml+/-;Pum2-/- pups (Figure 22A, 22E). 
Puml-/-; Pum2+/- were significantly smaller than their littermates at ldpp, had no milk 
in their stomach, and died within 24 hours of birth (Figure 22B). Histological analysis of 
Puml-/-;Pum2+/- pups showed thymic necrosis, hepatic congestion, and hepatic atrophy 
(data not shown), but no obvious defects in heart, lung, kidney, spleen, or stomach. 
Puml -/-; Pum2 -/- mice are embryonic lethal by e8.5 
Blastocysts were isolated from the uteri of e3.5 mice and were genotyped by 
DNA extraction from single blastocysts followed by nested PCR. Of 52 blastocysts, four 
were Puml-/-;Pum2-/- (Figure 23 A, 23B), which is consistent with the expected 
Mendelian ratio, indicating that double knockout embryos are viable to e3.5. Of the four 
blastocysts, two were developmentally delayed and appeared morula-like without a 
defined blastocoel cavity (Figure 23A). The explanted blastocysts were cultured 
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Mstings: Puml •/-; Pum2 */• * Puml+/-;Pum2+/-
WT DHet Pum2-/- Pum1-/-
B 
1dpp 
Ratio Genotype Expected Observed 
1/16 wild Type 8 9 
1/16 Pum2 KO 8 9 
2/16 Pum2 Het 16 23 
2/16 Puml Het 16 26 
4/16 Double Het 32 BO 
2/16 Puml Het; Pum2 KO 16 13 
2/16 Puml IS); Pum2 Het 16 5 
1/16 Puml KO 8 12 
1/16 Double Knockout 8 0 
Total 127 
WT Pum1+/-;Pum2-/- Pum1-/-;Pum2+/-
A*g = 1.44g /Wg Awg = 0 90g 
n= 7 n = 2 
5dpp 
WT DHet Pum2-/- Pum1-/-
28dpp 
Puml / Pum2 Double Knockout Mice Are Not Viable At Birth 
• Expected • Observed 
WT Pum2-/- Pum2+/- Puml+/- Puml+/- Puml+/- Puml-/- Puml-/- Puml-/-
Pum2+/- Pum2-/- Pum2+/- Pum2-/-
Figure 22: Puml-/-; Pum2-/- double knockout mice are not viable at birth 
A) Expected and observed ratios from a Puml+/-; Pum2+/- (Dhet) self-cross. 
Phenotypes of ldpp (B), 5 dpp (C), and 28dpp (D) offspring. E) Graphical 
representation of expected versus observed genotypes from mating strategy in panel A. 
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Puml -/-; Pum2 -/• 
451-4 600-7 
B Genotyping Blastocysts 
Puml +/-; Pum2 +/- x Puml +/-; Pum2 +/-
n = 52 
• Expected 
• Observed 
WT Pum2 Het Pum2 KO Puml Het Double Puml Het, Puml KO Puml KO, Double 
Het Pum2 KO Pum2 Het Knockout 
Figure 23: Puml"' ;Pum2embryos are viable at e3.5 but delayed in development 
A) Blastocysts were flushed from e3.5 uteri in M2 media and cultured overnight in 
KSOM (e4.5). DNA was isolated from single blastocysts and used in two nested PCR 
reactions to genotype Puml and Pum2. 4 out of 54 blastocysts were Puml-/-;Pum2 -/-. 
Of these 2 appeared morula-like with no detectable blastocoels (689-8,461-7). 
B) Quantification of observed and expected Mendelian ratios of genotypes. 
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overnight in KSOM, and all genotypes, including the two delayed Puml-/-;Pum2-/-
embryos, appeared to have developed a blastocoel by e4.5 (Figure 23A). 
To further pinpoint the timing of embryonic lethality of Puml-/-;Pum2-/- embryos 
I next analyzed e8.5 embryos. Genotyping was performed on the yolk sacs of e8.5 
embryos, or on the extraembryonic tissue of developmentally-delayed embryos that had 
not yet formed yolk sacs, and pups were fixed for further analysis. Of 36 embryos, two 
Puml-/-;Pum2-/- embyos were recovered that were significantly smaller and 
developmentally delayed compared to all other embryos (Figure 24A, 24B). Dissection 
of these two embryos revealed a primitive head fold but overall lack of tissue with 
especially thin neural tissue (Figure 24A). These major defects may reflect the terminal 
phenotype and possible arrest point of the mutant embryos. Consistent with this, no 
Pum-/-;Pum2-/- embryos were recovered at e9.5 (Figure 25B )or el2.5 (Figure 26B), 
indicating that Puml/Pum2 double mutants are embryonic lethal by e8.5. Puml-/-
;Pum2+/- embryos recovered at e9.5 showed developmental delay and posterior 
hypoplasia, with normal-appearing heart morphology and somite development (Figure 
25A). Puml-/-; Pum2 +/- embryos were smaller than their littermates at el2.5, but 
showed no obvious developmental defects (Figure 26A). Yolk sacs from el2.5 Puml-/-
;Pum2+/- embryos were darker and more friable than yolk sacs from all other genotypes 
(Figure 26A), suggesting that both defects in the supporting structures and embryonic 
tissue may be contributing to the phenotype of Pum-deficient embryos. 
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B Genotyping e8.5 
Puml +/-; Pum2 +/- x Puml +/-; Pum2 +/-
n = 36 
• Expected 
• Observed 
WT Purr>2Het Pum2 KO Puml Het Double Het Puml Het, PumlKO PumlKO, Double 
PurrrtKO Pum2Het Knockout 
Figure 24: Puml -/- ;Pum2 -/- double knockout embryos are viable at e8.5 but 
appear developmentally delayed and have reduced tissue mass 
A) The Pum-/-;Pum-/- embryo is smaller than WT e8.5 embryos as shown in the upper 
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Genotyping e9.5 embryos 
Puml +/-; Pum2 +/- x Puml +/-; Pum2 +/-
n = 19 
I Expected 
I Observed 
WT Pum2 Het Pum2 KO Puml Het Double Puml Het, Puml KO Puml KO, Double 
Het Pum2 KO Pum2 Het Knockout 
Figure 25: Puml-deficient embryos are smaller at e9.5 
A) Phenotype of e9.5 embryos according to genotype; Puml-/- embryos are smaller. 
B) Quantification of the expected versus observed Mendelian ratios; no double 




B E12.5 Embryos 
l Expected • Observed 
WT Pum2-/- Pum2+/- Puml+/- Purnl+/- Puml+/- Puml-/- Puml-/- Puml-/-
Pum2t/- Pum2-/- Pum2+/- Pum2-/-
Figure 26: Phenotype of el2.5 embryos 
A) Phenotype of el2.5 embryos according to genotype. 
B) Quantification of the expected versus observed Mendelian ratios; no double 
knockout embryos were recovered at el2.5. 
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Discussion 
Puml and Pum2 are expressed predominantly in the cytoplasm of mouse 
embryonic stem cells, which is consistent with the hypothesis that the primary role of 
Pumilio proteins is translational regulation of cytoplasmic mRNA transcripts. There have 
been some reports of Pumilio function in the nucleus; Trypanosome homologue TbPUF7 
is located in the nucleolus (Droll et al. 2010), and two of the twenty-five Pumilio proteins 
in Arabidopsis shuttle between the cytoplasm and nucleus (Tam et al. 2010), but to date 
all known mammalian functions of Pumilio proteins occur in the cytoplasm. In human 
adipose-derived stem cells, PUM2 is diffusely distributed in the cytoplasm, particularly 
in granular structures that may represent stress granules or P-body-like structures 
(Shigunov et al. 2012). The localization of Puml and Pum2 is similar in mouse 
embryonic stem cells, which is consistent with the hypothesis that the Pumilio proteins 
interact with high-molecular-weight regulatory complexes at these sites to mediate 
translational control. The enrichment of Puml around the nuclear periphery of some 
mitotic cells (Figure 6C, arrow) may explain the finding of Puml signal in the nuclear 
fraction after nuclear/cytoplasmic fractionation (Figure 6A), and suggests that this signal 
represents Puml association with the nuclear membrane. 
Western blotting with anti-Pumilio antibody in human adipocyte protein extracts 
labels two bands that are of very close molecular weight (Shigunov et al. 2012) and likely 
represent a post-translational modification of the protein. A similar doublet is present in 
western blots of mouse ES cells when low amounts of protein are loaded (data not 
shown), but is not visible at higher protein concentrations due to the abundance of the 
protein in these cells (Figure 6A). Phosphorylation of human PUM1 enhances its binding 
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to mRNA targets (Kedde et al. 2010), and Xenopus Pum2 is phosphorylated during 
oocyte maturation (Ota et al. 2011). Taken together, these data suggest that the 
phosphorylation of Pumilio proteins is conserved in many species and likely represents 
an additional layer of Pumilio regulation. 
Pum proteins are highly expressed in proliferating cells (Lin lab, unpublished 
data) and have an evolutionary conserved function in promoting mitosis (Ariz, Mainpal 
and Subramaniam 2009). In S. cereviseae , reduction of PUF5 results in the decreased 
proliferation of cells while overexpression of PUF5 results in increased proliferation 
(Kennedy et al. 1997). C. elegans FBF-2 inhibits cell entry into meiosis by 
translationally regulating gld-1 mRNA (Crittenden et al. 2002), while PUF8 promotes 
mitotic proliferation (Ariz et al. 2009). Expression of human pum2 mRNA transcripts is 
elevated in adipose-derived stem cell cultures with increased levels of proliferation when 
compared to cultures of the same cells with lower levels of proliferation, and pum2 
knockdown results in impaired proliferation of these cells (Shigunov et al. 2012). My 
finding that Puml-/-, and Puml-/-; Pum2+/- mES cells have increased cell doubling 
times compared to wild type cells is consistent with the known role of Pumilio proteins in 
the regulation of self-renewal and proliferation. Interestingly, Puml-/- and Puml-/-
;Pum2+/- cells have slower cell doubling times, but are eventually able to achieve the 
same rate of proliferation as indicated by the slope of the growth curve (Figure 10,21). 
This suggests that Pum-deficient cells are less able to seed new colonies than wild type 
cells, or may have greater defects at low density due to cell-cell or cell-matrix adhesion 
defects rather than direct deficiencies in mitotic division. 
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Puml-/-;Pum2-/- ES cells are unable to survive in vitro when derived from either 
blastocysts or transfection of Cre recombinase into Puml flox/flox ; Pum2 flox/flox cell 
lines, suggesting an essential function of Pumilio proteins in the self-renewal of 
embryonic stem cells. It is possible that cells lacking all Pumilio proteins are not viable, 
or they have severe growth defects that make positive selection during transfection and 
clonal expansion highly inefficient. To avoid these pitfalls, my future work is focused on 
generating ES cell lines that express floxed Puml and Pum2, and an inducible Cre driven 
by a doxycycline-responsive promoter. This will allow for the generation of Puml 
flox/flox; Pum2 flox/flox ES cells that are poised for deletion by the addition of 
doxycycline to the media, facilitating a definitive assessment of the necessity of Pumilio 
proteins for ES cell self-renewal. 
FACS-based cell cycle analyses of Puml-/- and wild type ES cells showed 
approximately the same number of Puml-/- cells in S phase, but an increased proportion 
of necrotic and apoptotic Puml-/- cells by annexin V and cleaved caspase-3 staining 
(Figure 12) suggested that Pumilio is more involved in the regulation of cell death 
pathways than proliferation pathways. These data are consistent with Shigunov et al., 
who observed a 13-37% decrease in BrdU uptake in adipose-derived stem cells treated 
with Pum2-siRNA (Shigunov et al. 2012), and Chen et al., who demonstrated a 
significant increase in apoptosis in the Puml-/- testis (Chen et al. 2012). The slower 
doubling time of Puml-/-; Pum2+/- cells as compared to Puml-/-, in context with the 
normal doubling times of Puml+/-, Pum2+/-, and Pum2-/- cells suggests that these 
proteins are partially, but not completely functionally redundant in their regulation of cell 
division and apoptosis. In vitro and in vivo, Puml appears to play a more important role 
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than Pum2, as evidenced by the findings that Puml-/- ES cells grow more slowly than 
Pum2 -/- ES cells (Figure 10, 21), Puml-/- mice are smaller than Pum2 -/- mice (Figures 
14,15,19, 20, 22), and Puml+/-;Pum2-/- mice are viable to adulthood but Puml-/-
;Pum2+/- mice are not (Figure 22). Taken together, these data indicate that one copy of 
Pum2 provides the least amount of mammalian Pumilio protein that is compatible with 
life, that Puml and Pum2 are partially functionally redundant, and that Puml is likely 
playing a more important role than Pum2. 
Siemen et al. reported that Pum2-deficient mice are hyperactive and have slightly 
lower body weights (1.7 - 4.4g less) than wild type littermates (Siemen et al. 2011). Our 
data show a significantly decreased body weight for Puml-/- mice, but not for Pum2-/-
mice. This discrepancy could result from different genetic backgrounds, or differences 
between our conditional knockout strategy and the gene trap mutation strategy used by 
Siemen et al. My data suggest that the decreased weight of Pum-deficient mice is 
unlikely to be caused by hyperactivity, as Puml-/- mice are even smaller than their 
littermates in utero (e9.5 - Figure 25A, el2.5 -Figure 26A) and at birth (Figure 22). 
Moreover, Puml -/- mice have uniformly smaller organs - including the brain, kidneys, 
and liver - suggesting that their diminutive size may be a result of impaired cellular 
proliferation or increased cell death, and not of increased energy metabolism or caloric 
expenditure. 
Given the intrinsic roles of Pumilio proteins in the regulation of basic cellular 
functions such as cell proliferation and cell death, it is not surprisingly that these proteins 
are essential for early development. Wang et al. have reported that Pum2 is expressed in 
all zebrafish balstomeres from the 1-cell to the sphere stage, with accumulation of the 
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protein in the head and tail during the 3-somite stages (Wang et al. 2012). Human puml 
and pum2 mRNA are both expressed in fetal ovary, testis, brain, liver and heart (Moore et 
al. 2003), suggesting that these proteins play a role in diverse tissues in the developing 
fetus. The developmental delay of two out of four Puml-/-;Pum2-/- blastocysts 
demonstrated in this study provides further support that Pumilio proteins function very 
early during development. There are natural variations in the timing of fertilization of 
individual oocytes in the mouse, resulting in some heterogeneity in the staging of 
embryonic development in a litter at any given time point. However, the significant 
delay and decrease in tissue mass of the e8.5 Puml-/-;Pum2-/- embryos suggests that this 
is not due to a delay in fertilization, but rather due to Pumilio-specific defects in 
embryonic patterning and development. 
The absence of viable e9.5 and el2.5 Puml-/-; Pum2-/-embryos (Figures 25, 26) 
suggests that the double mutant is embryonic lethal at e8.5 with tissue resorption 
occurring by e9.5. Puml-/-;Pum2-/- embryos at e8.5 are smaller and appear 
developmentally delayed to an approximately e6.5 or e7.5 size. Gastrulation occurs in 
the mouse embryo at e6.5, and requires a burst of cellular proliferation after which cells 
ingress through the primitive streak to form the three primary germ layers that give rise to 
all tissues of the body - endoderm, mesoderm, and ectoderm (Tam and Loebel 2007). In 
addition, normal embryonic development requires a drastic increase in the rate of cell 
cycle progression during this phase of development. Epiblast cells of e5.5 - e6.0 
embryos have a mean cell cycle time of 11.5 hours, while epiblast cells of e6.5 - e7.0 
embryos have a mean cell cycle time of only 4.4 hours (Hogan 1994). Given the 
established role of Pumilo proteins in promoting mitosis, and the proliferative defects 
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present in Puml-deficient embryonic stem cells, it is possible that Puml-/-;Pum2-/-
embryos are unable to undergo this rapid proliferation required to meet the demands of 
gastrulation and subsequent embryonic patterning. This may explain the delayed 
development and smaller appearance of e8.5 Puml-/-;Pum2-/- embryos. It is also 
possible that these embryos are not able to successfully form all three germ layers, as 
suggested by the decrease in the total amount of embryonic tissue and thin primitive 
neural tissue (Figure 24A), or that the function of extraembryonic support structures is 




mRNA Targets and Protein Partners of Pumilio in mES Cells 
Introduction 
mRNA Targets of Pumilio Proteins 
The mRNA targets of Pumilio proteins have been identified in yeast (Gerber, 
Herschlag and Brown 2004), C. elegans (Kershner and Kimble 2010), Drosophila 
(Gerber et al. 2006), mouse (Chen et al. 2012), and human (Morris et al. 2008, Galgano et 
al. 2008, Hafner et al. 2010). The crystal structure of human PUM1 reveals a concave 
surface of the Pum-HD consisting of 22 basic residues that contact phosphates within the 
RNA binding sequence (Wang et al. 2001). Pumilio binds to the Nanos Response 
Element (NRE) in target mRNAs with subnanomolar affinity (Zamore et al. 1999). The 
affinity of mRNA binding may depend partially on the protein partners of Pumilio as 
previously described. Pumilio proteins preferentially bind to mRNA transcripts that 
encode transcription factors and proteins involved in the regulation of cell proliferation 
and differentiation, embryonic patterning, and metabolism (Figure 27). Each of the five 
Pumilio proteins in yeast binds to specific subsets of functionally related mRNA (Gerber 
et al. 2004). Yeast Puf5 binds exclusively to mRNA transcripts that encode 
mitochondrial proteins (Foat et al. 2005), providing evidence for the hypothesis that these 
proteins comprise an RNA operon model in which RNA-binding proteins coordinately 
* Bioinformatic analysis of the microarray data presented in this chapter was conducted 
by Xiao Huang. 
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Organism Pwf Target Modo of Biological process Rcf. Number at Rcf, 
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Figure 27:Pumilio binds functionally-related mRNAs in many species 
Identified mRNA targets of Pumilio in Drosophila, C. elegans, and human. Figures 
modified from Quenault, Lithgow and Traven (2011) 
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regulate the expression of functionally related mRNA transcripts (Keene 2007, Keene 
and Tenenbaum 2002). Further evidence for this model was provided by Morris et al., 
who in 2008 identified 726 mRNA targets of human Puml in HeLa S3 cells, many of 
which were functionally clustered into gene categories involved in transcription, 
nucleotide metabolism, and cell proliferation and differentiation (Morris et al. 2008) . 
Likewise, Puml regulates multiple components of p53-dependent apoptosis pathways in 
the mouse testis (Chen et al. 2012). 
The identification of Pumilio mRNA targets involved in embryonic patterning, 
cell polarity, and cell cycle regulation suggest that Pumilio proteins may play a role 
during early development or in multipotent cells. Shigunov et al. used a modified R1P-
Chip method to identify the mRNA targets of human PUM2 in adipose-derived stem cell 
(ASC) cultures (Shigunov et al. 2012). Gene set enrichment analysis revealed that many 
of the targets were components of gene networks regulating cell growth, proliferation, 
and gene expression. The mRNA targets of human PUM1 and PUM2 overlap 
significantly (Morris et al. 2008, Hafiier et al. 2010), providing further evidence that 
these proteins may be partially redundant. PUM2 binds to and represses mitogen 
activated protein kinase (MAPK)- encoding mRNAs in human embryonic stem cells (Lee 
et al. 2007). However, the mRNA targets of Puml, as well as the genome-wide targets of 
these proteins in embryonic stem cells have yet to be identified. Since Pumilio proteins 
likely serve divergent functions depending on the pool of expressed mRNA and the 
tissue-specific protein binding partners present in the cell, identifying Pum-mRN A 
interactions in ES cells may help uncover novel roles of the protein. 
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Protein Partners of Pumilio Proteins 
In many model systems, the activity of Pumilio is thought to require the 
recruitment of Nanos. Nanos is necessary for the Pumilio-mediated translational 
repression of hunchback mRNA during body patterning in Drosophila embryos (Barker 
et al. 1992, Murata and Wharton 1995), for the repression of Cyclin B mRNA in the 
Drosophila germline (Kadyrova et al. 2007), and for the repression of paralytic (para) 
mRNA that regulates sodium current in Drosophila motoneurons (Muraro et al. 2008). 
The functions of Pum and Nanos are intricately linked, as mutating either protein in flies 
results in the same phenotypic defects (Parisi and Lin 2000). Pumilio-Nanos interactions 
are also conserved in Xenopus (Nakahata et al. 2001), C. elegans (Kraemer et al. 1999), 
and in human germ cells (Jaruzelska et al. 2003). It has even been suggested that the 
main function of Pumilio proteins is the recruitment of Nanos proteins (Kadyrova et al. 
2007). However, Nanos is not necessary for Pumilio-mediated translational repression in 
yeast or for the repression of bicoid mRNA in the anterior of the Drosophila embryo 
(Gamberi et al. 2002), suggesting that some Pumilio functions are independent of Nanos. 
Several other protein partners of Pumilio have been identified in different organisms, and 
the functional implications of these interactions are just beginning to be understood. 
Pumilio proteins mediate translational repression by both poly(A)-dependent and 
poly(A)-independent mechanisms. Puf5 binds directly to the Pop2 subunit of the Ccr4-
Pop2-NOT mRNA deadenylase complex in yeast (Goldstrohm et al. 2006) and decreases 
mRNA stability and translation by shortening the poly(A) tails of its targets (Preiss, 
Muckenthaler and Hentze 1998). This mechanism of repression is functionally 
conserved, as Pumilio proteins also bind to the Ccr4-Pop2-NOT deadenylase complex in 
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Drosophila (Kadyrova et al. 2007), C. elegans (Suh et al. 2009) and humans (Quenault et 
al. 2011). Although PUF proteins almost always bind to the 3'UTR of mRNAs, they can 
also act on the 5' cap of the mRNA due to the "closed-loop"structure of mRNAs present 
in cells that brings the 5' and 3' ends of the mRNA in close proximity. In this manner 
Dhhl and Dcpl mediate 5' decapping and mRNA repression (Coller and Parker 2005). 
Likewise, in Xenopus oocytes Pum2 binds directly to the 5' 7 methylguanylate (7mg) cap 
structure and represses translation by outcompeting eIF4E binding at this site which is 
necessary for translational initiation (Cao et al. 2010). In human germ cells, the fiinction 
of PUM2 is thought to depend on its interactions with the proteins Deleted in 
Azoospermia (DAZ), DAZ-Like (DAZL) and BOULE (BOL) (Moore et al. 2003, Urano 
et al. 2005). In Drosophila, it has been suggested that the functional Pumilio regulatory 
unit consists of two Pumilio proteins bound to a single mRNA NRE sequence (Gupta et 
al. 2009). The functional dimerization of Pumilio proteins has yet to be demonstrated in 
other species. 
In this chapter, I identify the mRNA targets bound to Pumilio 1 and Pumilio 2 in 
mouse ES cells by RNA Immunoprecipitation-Microarray (RIP-Chip). Puml binds to 
approximately 2000 mRNA targets and Pum2 binds to approximately 400 mRNA targets 
that comprise a subset of Puml targets. Both proteins bind preferentially to genes 
involved in cell cycle regulation, embryonic patterning, and transcriptional regulation. 
Several of the identified mRNA targets are upregulated at the protein level without 
corresponding changes in the mRNA level in Puml-deficient ES cells, indicating the loss 
of translational repression by Pumilio proteins. Puml and Pum2 bind to and regulate 
their own mRNA transcripts in a feedback loop that likely buffers the level of Pumilio 
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proteins in the cell. I identified three novel protein binding partners of Pumilio 1 in 
mouse ES cells: Anaphase Promoting Complex Subunit 1 (APC1), Regulator of 
Nonsense Transcripts 1 (RENT1), and Zinc Finger Nuclease 198 (ZNF198) by co-
immunoprecipitation followed by mass spectroscopy. Puml directly interacts with these 
proteins, and several known mRNA targets of Puml also co-immunoprecipitate with 
Rentl. The identification of the interacting proteins and target mRNAs of Pumilio in ES 
cells will reflect its mechanism of action in these cells. 
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Results 
Puml binds to the mRNAs of1947 genes in mES cells 
Since engineered PUF proteins and exogenous tagged Pum-HD domains do not 
always bind to mRNA targets with the same affinity as endogenous Pum proteins 
(Filipovska et al. 2011), an antibody against endogenous Puml was used to pull down the 
protein and its associated mRNA targets in mouse ES cells. RNA-binding protein 
immunoprecipitation-microarray (RIP-Chip) experiments were conducted as has been 
previously described (Keene, Komisarow and Friedersdorf 2006) on total cellular mES 
lysate. Co-immunoprecipitated mRNAs were amplified and hybridized to an Illumina 
Mouse Ref6 v2 Expression BeadChip Microarray. Data were normalized using loess 
regression and quantile normalization, and the p values and fold enrichment for each 
probe were analyzed by a Volcano plot and heat maps of probe enrichment (Figure 28, 
Figure 29). 
1947 unique mRNAs were significantly enriched in the Puml IP as compared to 
the negative control (fold enrichment > 1.5, p value <0.001). Of these, the top 500 by p 
value and fold enrichment (Appendix A) were assessed by Gene Set Enrichment Analysis 
(GSEA) to assign the enriched targets to functionally related gene sets. GSEA revealed 
that Puml mRNA targets are particularly enriched for genes involved in transcriptional 
regulation (23%), cell growth, maturation and death (20%), protein phosphorylation 
(13%), GTPase activity (9%), embryonic development (8%), ubiquitination (6%), cell 
cycle regulation (3%), and chromatin regulation (3%) (Figure 29). Several individual 
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Figure 28:Puml RNA Immunoprecipitation - Microarray (RIP-Chip) 
A) Log intensity of the IP (y axis) plotted against log intensity of the negative control 
(y axis), indicating enriched targets in the IP. B) IP replicates are consistent with one 
another. C) Heat map of top enriched mRNA targets by fold expression. Isolated 
mRNA from RIP-Chip before (D) and after (E) amplification prior to hybridization to 
an Illumina Mouse Ref6 v2 Expression Microarray. (Bioinformatics by X. Huang) 
78 
Enrichment of Puml mRNA targets 
Blocking Pep 
• Puml IP 
6APDH CydinBl p38 
B 






Gene set enrichment analysis 
•  .  - V , : .  
nuclear compartment 
regulation of transcription 
iiijlsp-
chromatin modification 
jrotein phosphorylation regulation 
protein catabolic process 
cell cycle regulation 
nucleotide binding 
5.1 0.0 0.1 0.2 0.3 04 
Log Fold ol Enricftmeni-lP <wer CT (base=2) 
Figure 29: Gene set enrichement analysis of Puml mRNA targets 
A) qRT-PCR confirmation of the enrichment of specific mRNA targets in the co-
immunoprecipitate of Puml. B) Volcano plot indicating the fold enrichment (x axis) 
and p value (y axis) of the mRNA targets of Puml. Purple arrow indicates direction of 
top hits based on both fold enrichment and p value used in subsequent analyses. C) 
Gene set enrichment analysis of Puml mRNA targets. (Bioinformatics by X. Huang). 
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targets including Cyclin Bl, Suppressor of zeste 12 homolog (Suzl2), and B lymphoma 
Mo-MLV insertion region 1 homolog (Bmil) were verified to be enriched in the Puml IP 
by quantitative RT-PCR (Figure 29B). Sequence analysis of the mRNAs co-
immunoprecipitated with Pumilio confirmed the presence of putative NRE sequences 
within the 3' UTR of these mRNAs (data not shown). 
Puml translationally represses Cyclin Bl, Cyclin El, Cyclin E2, and Pum2 
To determine if the identified mRNA targets of Puml are translationally 
controlled by Pumilio in mouse embryonic stem cells, I compared the steady-state mRNA 
and protein levels of several targets in wild type, Puml +/-, and Puml -/- ES cell lines 
described in Chapter 2. There were no significant differences in the mRNA levels of 
Pum2, Cyclin Bl, or Cyclin E2, while there was a slight decrease in the mRNA level of 
Cyclin El in Puml -/- cells as compared to Puml Flox/Flox cells (Figure 30A). 
Conversely, the protein levels of Pum2, Cyclin Bl, Cyclin El, and Cyclin E2 were 
significantly increased approximately two-fold in Puml-deficient ES cells (Figure 30B). 
These data indicate that Puml translationally represses Pum2, Cyclin Bl, Cyclin El, and 
Cyclin E2 in vivo. 
To further assess the translational repression of Puml in ES cells I utilized a 
luciferase reporter construct in which the 3' UTRs of known and novel Puml mRNA 
targets were cloned directly downstream of the protein coding sequence of firefly 
luciferase (Figure 31). All 3' UTR sequences assayed contained one or more putative 
Pum-binding NRE site by sequence analysis for binding motifs. A plasmid encoding 
renilla luciferase was co-transfected into cells as a transfection control, and the ratio of 
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Figure 30: Pum 1 translationally represses mRNA targets in mES cells 
A) qRT-PCR indicates the steady-state levels of specific Puml mRNA targets in Puml 
floxed and Puml -/- ES cells. Most are unchanged or slightly downregulated. 
B) Western blot analysis of total cellular lysate of wild type, Puml +/-, and Puml -/-
ES cells probed with antibodies against proteins encoded by Puml mRNA targets 
indicate that Cyclin Bl, Cyclin El, Pcna, and Pum2 are upregulated approximately 
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Figure 31: The 3'UTR of Puml mRNA targets is sufficient for translational 
regulation in vitro 
Luciferase reporter assays using a firefly luciferase vector alone (pGL3) or with the 
3'UTR sequence of Cyclin Bl or Suz 12. UGU -> AUA mutations were introduced 
into each of the potential NREs of Cyclin Bl to abolish Pumilio binding (Mut 1-3). 
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firefly to renilla luciferase was used to assay the translational effects of Pumilio proteins 
on target mRNA sequences in vitro. The presence of the full-length Cyclin Bl 3'UTR 
downstream of the firefly luciferase gene results in an 80% reduction of firefly luciferase 
expression levels (Figure 31). Similarly, the presence of the full-length 3' UTR of 
Suzl2, a novel mRNA target identified in the genome-wide screen reported in this study, 
results in an over 90% reduction in expression levels of firefly luciferase in mouse ES 
cells (Figure 31). This repression was identical in wild type and Puml-/- cells (Figure 
31), indicating that Puml alone is not responsible for the 3'UTR-mediated repression of 
these constructs in vitro. 
Pum2, a mammalian homolog that contains an RNA-binding sequence nearly 
identical to Puml may be responsible for the observed repression in the absence of Puml 
It is also possible that other RNA-binding proteins present in the cell are responsible for 
the 3'UTR-mediated translational repression. To address this possibility and to 
determine if Pumilio-binding is responsible for the observed translational repression of 
the luciferase constructs, I generated mutations in the putative NRE sequences within the 
3'UTR of Cyclin Bl. Three putative NRE sequences were identified in the 3'UTR of 
Cyclin Bl, and nucleotides within the eight-nucleotide core of each putative NRE were 
mutated from TGT to ATA by site-directed mutagenesis. This mutation has previously 
been shown to effectively abolish Pum-binding in vitro (Zamore et al. 1999). Mutation 
of each individual NRE in Cyclin Bl resulted in a 10% to 40% release of the sequence-
dependent suppression of luciferase expression levels (Figure 31). Mutation of all three 
putative NREs within the 3' UTR of Cyclin Bl allowed for a 50% increase of firefly 
expression (Figure 31). 
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Pum2 binds to the mRNAs of437 genes in mES cells 
The RNA binding domain of murine Pum2 is 91% identical and 97% similar to 
that of Puml (Jenkins et al. 2009); thus it is likely that these proteins have similar or 
overlapping target sets. To investigate this possibility I conducted a RIP-Chip 
experiment using an antibody against endogenous Pum2 to identify its in vitro mRNA 
targets. The experimental conditions and normalization of data were identical for the 
Puml - and Pum2- RIP-Chips to allow for a direct comparison of data sets. Gene set 
enrichment analysis revealed that like Puml, Pum2 binds to mRNAs in mES cells that 
are functionally enriched for proteins involved in transcriptional control, cell cycle 
regulation, and metabolism (Figure 32). Further analysis revealed that the of the 437 
most enriched mRNA targets of Pum2 (fold enrichment >1.5, p value <0.001), 366 
comprised a subset of Puml targets, while 71 were Pum2-specific (Figure 32). 
Puml is a component of a 450 kDa complex and Pum2 is a component of a 350 kDa 
protein complex in mES cells 
To identify the protein binding partners of Puml in mouse embryonic stem cells, I 
conducted size exclusion chromatography to determine the size of the Pumilio protein 
complex. Total lysate from mouse ES cells was collected and fractionated using a 
Superdex 200 column, and fractions of known molecular weights were immunobloted 
with anti-Pumiliol and anti-Pumilio2 antibody. Puml is present as part of a 440-660 
kDa protein complex, and Pum2 is present in a 350 kDa complex that does not co-
fractionate with Puml (Figure 33). Since Pumilio proteins are well-characterized RNA-
binding proteins, this complex may include proteins that are indirectly bound to Pumilio 
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Figure 32: Pum2 binds to a subset of Puml mRNA targets 
A) Experimental design for the Pum2 RIP-Chip. B) Venn diagram indicating the 
overlap of Puml and Pum2 targets (366). C) Gene set enrichment analysis of the 366 
genes that are bound both by Puml and Pum2. (Bioinformatics by X. Huang). 
85 
B 
O — ci • • © ri » o 
- - - _ n rf, ? if, « i-» « - - - - n m ^ \o r> « c\ -<  <  < O Q f i Q e Q e Q g > S a 5 a 5 g > O Q g ) C Q O O O O O O O O O O  
Piunl 
Pum2 
C\ vo V£> 
o •rr *5t 
o o o 
-> i « o cm 1 



























£. 3 3 .>* «•> 2? «/» — w u *•» 05 a» o ^ . 
2 S£ 3 =. 
-O 






Figure 33: Puml elutes as part of a 450-660 kDa complex, and Pum2 elutes as 
part of a 350 kDa complex in mES cells 
A) Size exclusion chromatography followed by SDS-PAGE and western blotting 
indicates the size of the Puml - and Pum2- containing complexes; known molecular 
weight markers indicated above. B) The Puml complex size is not dependent on the 
presence of RNA. C) Puml is efficiently pulled down in a Puml Co-IP. D) In 
addition to Puml, six bands are visible in the Co-IP of Puml on silver stain. 
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via its mRNA targets, but not directly bound to Pumilio itself. To exclude this possibility 
I pre-treated mES lysates with RNAse inhibitors or RNAse prior to column fractionation. 
RNAse treatment did not significantly change the size of the fractions in which Puml 
elutes (Figure 33B), suggesting that Puml is present in a 440-660 kDA complex 
mediated by protein-protein, and not protein-RNA interactions. 
To identify the protein partners of Puml in mES cells, co-immunoprecipitation 
experiments were performed using an antibody against endogenous Puml in pooled 
fractions of mES lysate (B3-B7, Figure 33). Puml was detected in the IP but not in the 
presence of excess blocking peptide against which the antibody was raised (Figure 33). 
Proteins were eluted from the beads in SDS-containing loading buffer and separated by 
gel electrophoresis (SDS-PAGE) and silver stained to detect proteins present in the co-
immunoprecipitate of Puml. A strong band was visible below 150 kDa that labeled with 
anti-Puml antibody by western blotting (Figure 33C). Six additional bands were visibile 
in the IP lane, but not the negative control, at approximately 250,230, 200, 110, 70, and 
45 kDa (Figure 33D). The remainder of the IP samples were separated by SDS-PAGE 
and stained with Coomassie blue dye (data not shown). Bands present between 200-
250kDa, 120-15 OkDa, and 60-80kDa were excised and sent for high pressure liquid 
chromatography (HPLC) and mass spectrometry analysis. Peptides within the Pumilio 1 
protein were isolated as well as three novel proteins: Anaphase-promoting complex 
subunit 1 (APC1), Zinc finger protein 198 (ZNF198), and Regulator of nonsense 
transcripts 1 (RENT1), also known as UPF1. 
87 
Puml directly binds to APC1, RENT1, and ZNF198 
Like Puml, RENT1 and ZNF198 are both present in the cytoplasm of mES cells, 
while APC1 is present equally in the cytoplasmic and nuclear fractions (Figure 34B). To 
verify the interactions between Puml and APC1, RENT1, and ZNF198,1 probed 
fractionated mES lysate with antibodies against each protein. APC1 and ZNF198 are 
both present in a protein complex size of approximately 500-700kDa with a peak 
intensity around 660kDa (Figure 34A). RENT1 elutes in two distinct peaks: one less 
abundant complex that co-fractionates with Puml at approximately 450-600 kDa, and 
another more abundant complex that elutes at approximately 250-350 kDa (Figure 34A). 
APC1, RENT1, and ZNF198 each co-fractionate with Puml, but are not found 
exclusively in Puml -containing complexes. APC1, RENT1, and ZNF198 are present in 
the co-immunoprecipitate of Puml but not in the negative control, indicating that Puml 
directly interacts with these proteins in vitro (Figure 34C). 
mRNA Targets of Puml and Pum2 are present in the co-immunoprecipitate of RENT1 
mRNA targets of Puml should be present in the co-immunoprecipitate of Puml 
and its interacting proteins if these binding partners are required for translational 
repression. To address this hypothesis co-IPs were conducted using antibodies specific to 
Puml, APC1, and RENT1, and associated RNAs were purified and assayed for 
enrichment by quantitative RT-PCR. The mRNAs encoding Puml, Pum2, Cyclin Bl, 
and Cyclin El were significantly enriched in the co-immunoprecipitate of both Puml and 
RENT1, but not of APC1 (Figure 35). These data suggest that Puml and RENT1 may 
interact on specific mRNA targets in vitro. 
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Figure 34: Puml directly binds to APC1, RENT1, and ZNF198 in ES cells 
A) Size exclusion chromatograpy reveals the size of the Puml-, APC1-, RENT1-, and 
ZNF198- containing protein complexes. B) Cytoplasmic/nuclear fractionation of total 
mES cell lysate reveals that RENT1 and ZNF198 are cytoplasmic proteins, while 
APC1 is both cytoplasmic and nuclear. C) APC1, RENT1, and ZNF198 are present in 
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Figure 35: mRNA targets of Puml are present in the co-immunoprecipitate of 
RENT1 
qRT-PCR analysis of Puml mRNA target enrichment in the co-immunoprecipitate of 
Puml, APC1, and RENTl. Several Puml targets are significantly enriched in the 




mRNA Targets of Pumilio Proteins 
This study reveals that Puml binds to mRNAs encoding 1947 proteins, and Pum2 
binds to mRNAs encoding 437 proteins in mouse embryonic stem cells, consistent with 
the approximate number of Pumilio targets in human HeLa cells (Morris et al. 2008) and 
in the mouse testis (Chen et al. 2012). Because the RIP-Chip experiments did not involve 
in vivo crosslinking of the RNA to the protein, it is possible that some Pumilio-mRNA 
targets may have re-assorted throughout the experimental conditions. Numerous novel 
targets of Puml and Pum2 were identified, and those involved in embryonic patterning 
and cell proliferation are particularly intriguing given the embryonic lethality of Pum-
deficient mice. Cyclin Bl, Cyclin El, Cyclin E2, and Pum2 proteins are upregulated in 
the absence of Puml without significant changes in their mRNA levels, indicating a 
conserved role of Pumilio as a translational regulator responsible for the repression of 
mRNA targets in embryonic stem cells. Targeting of Cyclin E by Pumilio proteins has 
previously been reported in C. elegans, in which the Pumilio homolog FBF indirectly 
regulates Cyclin E and Cdk2 levels to control the balance between self-renewal and 
differentiation in germline stem cells (Kalchhauser et al. 2011). 
Puml and Pum2 bind overlapping sets of mRNAs, many of which encode 
functionally related proteins. These data are consistent with previous reports of 
overlapping sets of mRNA bound to human PUM1 and PUM2 (Galgano et al. 2008), but 
to our knowledge represents the first model system in which Pum2 binds to an almost 
complete subset of Puml mRNA targets. The extent of functionally related target 
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mRNAs revealed by gene set enrichment analysis is consistent with the proposed role of 
Pumilio as a component of the RNA operon/regulon model (Hieronymus and Silver 
2004, Keene 2007, Chen et al. 2012). In the mouse testis, Puml represses several 
activators of p53 to regulate apoptosis during spermatogenesis (Chen et al. 2012). 
Although Puml depletion results in increased cell death in ES cells, it is unlikely that this 
results from dysregulation of p53-dependent apoptosis pathways because ES cells 
undergo ^^-independent apoptosis in response to DNA damage (Aladjem et al. 1998). 
The p5 3-mediated cell-cycle checkpoints that are present in differentiated cells are absent 
in undifferentiated, pluripotent stem cells, which do not localize p53 to the nucleus and 
instead undergo apoptosis through alternative signaling cascades (Aladjem et al. 1998). 
Interestingly, puml and pum2 mRNAs are among the most enriched mRNA 
transcripts bound to both Puml and Pum2 proteins in mouse ES cells. This is consistent 
with previously reported data that human PUM2 protein binds to Pum2 mRNA, 
suggesting that PUM2 can regulate its own mRNA (Shigunov et al. 2012). Puml 
expression is upregulated in the absence of Pum2, and Pum2 expression is upregulated in 
the absence of Puml in mES cells, suggesting that the reciprocal translational repression 
of these two proteins represents a feedback loop that regulates steady-state Pumilio levels 
in the cell. In the event of a mutation or deletion of either protein, the cell has a built in 
mechanism that may be used to increase Pumilio protein expression to meet the 
regulatory demands of the cell. Conversely, auto-regulation of Puml and Pum2 may 
prevent the overexpression of Pumilio proteins, as excess protein would likely be 
translationally repressed by the other Pumilio homologue. This is supported by the 
findings of Muraro et al. demonstrating that Drosophila Pumilio participates in a 
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negative-feedback mechanism with Nanos to protect neurons from overactivity of 
Pumilio (Muraro et al. 2008). A similar mechanism is likely at work in embryonic stem 
cells, in which the precise control of cell cycle genes such as cyclins and cyclin 
dependent kinases is essential for self-renewal and differentiation. 
Protein Partners of Pumilio Proteins 
Three novel binding partners of Puml were identified in mouse embryonic stem 
cells: Anaphase-Promoting Complex Subunit 1 (APC1), Regulator of nonsense 
transcripts 1 (RENTl),and Zinc Finger Nuclease 198 (ZNF198). APC1 is a 216 kDa 
meiotic checkpoint regulator that is the largest subunit of the Anaphase-Promoting 
Complex (APC) (or Cyclysome). During metaphase, sister chromatids are physically 
attached to one another via cohesin proteins at the metaphase plate. The APC triggers the 
end of mitosis and entrance into anaphase by tagging securin proteins with ubiquitin for 
degradation by the 26S proteasome (Alberts 2002). The degradation of securin releases 
separin, a protease that cleaves the cohesins and releases the two sister chromatids to 
move to opposite poles of the cell. The APC also tags Cyclin Bl, a known target of 
Pumilio proteins in many species, with ubiquitin for degradation by the proteasome at 
precise time points during the cell cycle. Cyclin Bl, in association with Cyclin 
dependent kinase 1 (Cdkl), is a critical component of cell cycle regulation that mediates 
chromosome condensation, spindle pole assembly, and the entrance of the cell into 
mitosis (Alberts 2002). An interaction between Puml and APC1, a component of the E3 
ubiquitin ligase that is intricately involved in cell cycle regulation, may lend insight into 
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the role of Puml in cell proliferation and self-renewal, and suggests a novel mechanism 
by which Pumilio proteins may mediate translational control. 
RENT1, a cytoplasmic protein involved in mRNA surveillance and nonsense-
mediated mRNA decay, may help explain the mechanism by which Puml degrades its 
target transcripts. In budding yeast, Pumilio proteins Puf4p and PufSp recruit the Ccr4-
Pop2-NOT deadenylase complex (Ulbricht and Olivas 2008), which facilitates 
translational repression by deadenylating the poly(A) tails of its target mRNAs. 
Similarly, Drosophila Pumilio, C. elegans FBF, and human PUM1 all mediate 
deadenylation of target mRNAs by recruitment of components of the Ccr4-Pop2-NOT 
deadenylase complex (Kadyrova et al. 2007, Suh et al. 2009, Goldstrohm et al. 2007). 
RENT1 (or UPF1) is a 123 kDa component of the exon junction complex that is involved 
in mRNA nuclear export and mRNA surveillance. mRNAs with an incomplete open 
reading frame or premature stop codon are targeted by the exon junction complex for 
mRNA decapping and nonsense-mediated mRNA decay. A Puml-RENT 1 interaction in 
embryonic stem cells suggests that Puml may translationally repress target mRNAs by 
recruitment of RENT 1 and subsequent mRNA deadenylation and decapping. 
Recruitment of ZNF198 may also play a role in Pumilio-mediated translational 
repression, but much less is known about the function of this protein. ZNF198 is a 158 
kDa cytoplasmic protein of the MYM-type 2 family that has been found to be rearranged 
in myeloproliferative disease (Kunapuli et al. 2006). ZNF198 directly binds to chromatin 
and may be a component of the chromatin remodeling complex, but its endogenous 
function is not well understood. 
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A Working Hypothesis 
Since Puml binds to and represses cyclin Bl mRNA, APC1 ubiquinates Cyclin 
Bl protein, and RENT1 is a component of the nonsense-mediated mRNA decay 
pathways, a Puml-APC 1-RENT 1 interaction leads to a hypothetical model in which 
Puml can translationally repress its targets by RENT 1-mediated mRNA destability and 
APC 1-mediated degradation of nascent polypeptide (Figure 36). Puml is present in a 
440 - 660 kDa protein complex, which does not exclude a direct physical interaction 
between APC1, RENT1, and ZNF198 since the combined molecular weight of all four 
proteins is approximately 630 kDa. All three proteins are present in the co-
immunoprecipitate of Puml, and Puml was detected in the co-immunoprecipitate of 
RENTl. Further evidence for a Puml-RENT 1 interaction is provided by the detection of 
Puml mRNA targets in the co-immunoprecipitate of RENTl, and a reduction in Puml-
mediated translational repression in vitro upon RENTl knockdown. Taken together, 
these data suggest that Puml binds to mRNA in a complex with RENTl that may 
mediate mRNA destability, and that Puml may be part of independent protein complexes 
with APC 1 and/or ZNF198. 
Puml and Pum2 elute in different fractions upon size exclusion chromatography, 
and were not shown to directly interact by co-IP (data not shown), indicating that Puml 
and Pum2 are not present in the same multiprotein complex in mES cells. This is 
consistent with biochemical data from Pumilio homologues in Xenopus, where Puml and 
Pum2 do not physically interact (Ota et al. 2011). The function of Drosophila Pumilio is 
thought to depend on its association with Nanos (Barker et al. 1992), and C. elegans 
FBF-mediated translational regulation requires an interaction between FBF and the 
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Figure 36:A potential model of Pumilio-mediated mRNA repression 
APC1 = Anaphase-promoting complex subunit 1. 
RENTl = Regulator of nonsense transcripts 1. 
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Nanos homologue NOS-3 (Kraemer et al. 1999). The Pum-Nanos interaction is 
conserved in humans; PUM2 directly binds Nanos 1 in the chromatoid body of human 
germ cells (Ginter-Matuszewska et al. 2011). However, none of the murine Nanos 
proteins were present in the co-immunoprecipitate of Puml in mouse embryonic stem 
cells (data not shown). Overall, these data suggest that Puml and Pum2 have 
independent functions, and that different protein partners of Pumilio homologues in 





Developmental biologists have been studying embryogenesis extensively since 
the 1800s, yet we are still far from a complete understanding of how a fertilized egg 
develops into an adult organism. Breakthroughs in early transplantation experiments, 
identification of differential gene expression, understanding the mechanics of 
gastrulation, and the recent identification of factors sufficient to transform differentiated 
cells back into undifferentiated cells have been peaks in scientific discovery along the 
way, and have greatly enhanced our understanding of early mammalian development. 
However, there are new signaling cascades, protein-protein interactions, and regulatory 
functions that are being discovered each year, illustrating that our current knowledge 
represents the tip of the iceberg of the incredibly intricate, complex systems that are 
coordinated during development. 
The evolutionary and functional conservation of Pumilio proteins from single-
celled organisms to higher multicellular eukaryotes such as plants and humans suggests 
that these proteins are essential to life. The partial redundancy of Puml and Pum2 in 
mammals lends further support to this theory, as it is evolutionarily advantageous to have 
a redundant copy of essential proteins to buffer against stochastic mutation or deletion. 
In this study, I characterized the two mammalian Pumilio homologs, Puml and Pum2 in 
mouse embryonic stem cells and in mice. Puml and Pum2 are RNA-binding proteins 
that bind to and translationally regulate thousands of functionally-related mRNA 
transcripts in the cell. Previous studies have demonstrated that Pumilio homologs are 
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essential for embryogenesis in Drosophila (Niisslein-Volhard et al. 1987), but relatively 
little was known about their function in mammals. Here I show that Puml and Pum2 
translationally repress genes involved in cell proliferation and cell cycle regulation in 
embryonic stem cells, and are essential for early murine embryogenesis. "Pumilio," 
which is Latin for "dwarf" has turned out to be a fitting name for both the original 
Drosophila embryo phenotype caused by disrupted anterior-posterior patterning as well 
as for the smaller Puml-deficient mouse phenotype and smaller, developmentally 
delayed Puml - and Pum2- deficient embryos. 
Pumilio proteins have been described as "regulators of regulators" (Morris et al. 
2008) because they control the expression of genes such as transcription factors and 
kinases that have many diverse downstream effects on gene expression. This study 
reveals that Pumilio proteins are global regulators of gene expression in embryonic stem 
cells, as evidenced by the finding that transcription factors are among the most highly 
enriched categories of mRNA bound to Puml and Pum2 in these cells (Figure 25, Figure 
28). Many of the identified mRNA targets of Pumilio proteins in mES cells are 
consistent with known targets that have been reported in other species and tissues. In 
addition, many novel mRNA targets of Puml and Pum2 were identified that are more 
enriched than known targets in ES cells. Of these, many transcripts encode proteins 
involved in cell cycle regulation and embryonic patterning. Given the growth defects and 
increased apoptosis in Puml-deficient cells, along with the abnormal embryonic 
development that results in early embryonic lethality in the Puml-/-; Pum2-/- mouse, 
dysregulation of these targets is likely to have significant functional consequences. The 
delicate balance of proliferation versus apoptosis, of self-renewal versus differentiation, 
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and of gene activation versus repression that must occur for normal embryogenesis to 
occur is incredibly complex, and it is likely directed by "master control" genes such as 
Pumilio that can coordinately regulate diverse cellular processes. 
Pum2 can only partially compensate for the loss of Puml. Puml-deficient mice 
have a more severe phenotype than Pum2-deficient mice, and Puml binds to more 
mRNAs in ES cells than Pum2, indicating that Puml has a more global role in gene 
regulation. The expression patterns of Puml and Pum2 are consistent with this 
hypothesis, as puml mRNA is expressed more ubiquitously in fetal and adult tissues than 
pum2 (Spassov and Jurecic 2003). Both the Puml and Pum2 RIP-Chip experiments 
reported here were conducted in wild type mouse ES cells; given the auto-regulation and 
partial functional redundancy of Puml and Pum2, it would be interesting to determine if 
the mRNA targets of Pum2 are expanded in a Puml-deficient background. In addition, 
the overlap of Puml and Pum2 targets presented here (Figure 28) represents the most 
highly enriched mRNA transcripts, which does not necessarily reflect the total binding 
partners of the proteins in living cells. 
I identified three novel binding partners of Puml in ES cells: APC1, RENT1, and 
ZNF198. Pumilio proteins are capable of translational regulation by the recruitment of 
various proteins and it is unclear which, if any, are essential for Pumilio function. 
Pumilio can destabilize its mRNA targets via recruitment of members of the Pop2p-Ccr4-
Not deadenylase complex, block translational initiation by binding to the 5' cap, or block 
translational elongation by binding to Ago-eEFl A (Friend et al. 2012). The interaction 
of Puml with APC1, RENT1, and/or ZNF198 raises the possibility that there may be 
more to the mechanism of Pumilio-mediated translational repression. Perhaps Puml 
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recruits the nonsense-mediated mRNA decay component RENT1 to deadenylate and 
dacap its target transcripts, while it simultaneously recruits the cyclosome component 
APC1 to tag any translated nascent polypeptide with ubiquitin for degradation by the 
proteasome. 
Friend et al. suggest three potential explanations for the finding that Pumilio 
proteins utilize multiple mechanisms of action: security, reversibility, and 
compartmentalization (Friend et al. 2012). Security is achieved because if one 
mechanism fails to completely silence a target mRNA, multiple mechanisms provide 
redundant plans to achieve the same goal. In this manner, recruitment of APC1 by Puml 
may represent an additional level of security, and to our knowledge represents the first 
evidence that these proteins may be implicated in protein degradation in addition to 
mRNA destability. If Pum proteins are unable to effectively silence target mRNAs by 
deadenylation, blockade of translational initation or translational elongation, perhaps the 
Puml-APCl interaction provides a final safeguard against aberrant protein expression by 
utilizing the ubiquitin-dependent proteosome degradation pathway. It makes 
evolutionary sense for proteins as crucial to cell growth and survival as the cyclins and 
cyclin dependent kinases, for which minor variations in the timing of expression can 
result in cell cycle arrest and death, to have multiple levels of control to keep the system 
in check. Second, reversibility allows Pumilio proteins to regulate protein expression in a 
spatial or temporal manner without completely abolishing the mRNA transcripts that may 
be required at a different subcellular site or during a different developmental timepoint. 
Lastly, compartmentalization allows one regulatory protein to have divergent effects on 
downstream targets depending on the protein binding partners, gene expression profile, 
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and local signals of the particular niche or tissue-type. Pumilio has been shown to both 
activate and repress the translation of its mRNA targets, and one mechanism by which it 
could achieve this is by spatially and temporally regulated interactions with its protein 
binding partners. 
To further address these possibilities, future work will focus on the necessity and 
sufficiency of APC1, RENT1, and ZNF198 for Pumilio-mediated translational repression 
of specific mRNA targets. It would be interesting to determine if the mRNA targets of 
Puml and Pum2 in ES cells have shorter poly(A) tails than non-bound mRNAs, and if the 
poly(A) tail length is dependent on the presence of functional RENT1. Likewise, 
investigations into the APC1-dependent ubiquitination of proteins encoded by Pumilio-
bound mRNA would lend insight into the function of the Puml-APCl complex. A 
genome-wide analysis of the proteome of wild type versus Puml-/-; Pum2-/- ES cells or 
embryo may reveal functional targets of Pumilio proteins, whose up- or down- regulation 
in the mutant background may result in the observed developmental defects. The 366 
common mRNA targets of Puml and Pum2 in ES cells are particularly intriguing targets, 
as these may represent the most evolutionarily conserved targets of Pumilio proteins. 
This study demonstrates that Puml - and Pum2- deficient mice are embryonic 
lethal between e8.5 and e9.5, and leads to many more questions about the mechanisms 
and developmental defects underlying this lethality. Expression levels of lineage-specific 
markers can be quantified by qRT-PCR, and the temporal and spatial expression of these 
markers can be assayed by whole mount staining. In particular, e7.5 and e8.5 embryos 
can be stained for Otx2 (forebrain and midbrain), FGF8 (fore-midbrain junction), FoxGl 
(neural development), Meoxl (somite development), and Twist 1 (mesodermal) to 
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determine whether lineage specification and early organogenesis occur normally in the 
absence of Pumilio proteins. Experiments are underway to develop an inducible Cre 
system in a Puml Flox/Flox ; Pum2 Flox/Flox mouse to inactivate expression of Pumilio 
proteins at various developmental time points. Are Puml and Pum2 required throughout 
embryogenesis, or only until gastrulation? Is the inactivation of Pumilio at later 
developmental time points or in the adult mouse compatible with life? The answers to 
these questions will help us map the function of Pumilio proteins throughout 





Mouse Embryonic Stem Cell Culture 
CCE cells (Stem Cell Technologies) were cultured on gelatin-coated tissue culture 
plates in the presence of sterile-filtered mES media with leukemia inhibitory factor 
(LIF)(ESGro Millipore), ES-qualified FBS (Gemini Bioproducts), NEAA, L-Glut, 
Pen/Strep, and Sodium Pyruvate. Media was changed every day and the cells were 
passaged every other day with TrypLE Dissociation Reagent (Gibco). 
ES Cell Derivation 
Mice matings were timed by checking for plugs (Day 0.5). Pregnant females 
were sacrificed at e3.5, and blastocysts were flushed from uteri in warm M2 media. 
Blastocysts were incubated in KSOM overnight under mineral oil in standard cell 
incubator conditions (5% C02), then plated on MEFs the following day for passage. The 
blastocysts were allowed to attach to the plates for 3 days, then the media was changed 
daily for another 3 days until the cells were passaged between day 7-10. All newly 
derived cell lines were assayed for Nanog and Oct 4 expression and were frozen at low 
passage number for use in all experiments. 
Antibodies 
The following antibodies were used: Pumilio 1 polyclonal goat anti-mouse 
antibody (Novus), Pumilio 2 polyclonal rabbit anti-mouse antibody (Novus), Pumilio 1 
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monoclonal rabbit anti-mouse antibody (Epitomics), Pumilio 2 rabbit anti-mouse 
monoclonal antibody (Epitomics), Cyclin B1 polyclonal rabbit anti-mouse (Cell 
Signaling), Cyclin E2 polyclonal rabbit anti-mouse (Cell Signaling), Suz 12 polyclonal 
rabbit anti-mouse (Cell Signaling), Cyclin A polyclonal mouse anti-human (Cell 
Signaling), CDK4 monoclonal mouse anti-human (Cell Signaling), Cyclin D1 
monoclonal mouse anti-human (Cell Signaling), Sox2 goat anti-mouse (Santa Cruz), 
Nanog polyclonal rat anti-mouse (eBioscience), APC1 polyclonal rabbit anti-mouse 
(Bethyl), RENT1 polyclonal rabbit anti-mouse (Bethyl), ZNF198 polyclonal rabbit anti-
mouse (Bethyl), RNA Pol II mouse anti-human (Abmart), GAPDH polyclonal rabbit 
anti-mouse (Sigma). 
Cytoplasmic/Nuciear Fractionation 
Mouse ES cell lysate was incubated on ice for 30 minutes, then spun at 1300g for 
10 minutes at 4 degrees. Supernatant was collected as the cytoplasmic fraction, and the 
spin was repeated to further purify the cytoplasmic fraction. The crude nuclear pellet was 
homogenized in lysis buffer, spun at 1300g for 10 minutes at 4 degrees. The supernatant 
was saved as a wash fraction, and the crude nuclear pellet was washed twice with lysis 
buffer to remove all cytoplasmic contaminants. The nuclear pellet was resuspended in 
the same volume of buffer as the cytoplasmic fraction for equal comparison. The nuclear 
pellet was sonicated with 5 second pulses at 12%, repeated 5 times, and incubated on ice 
for 5 minutes between pulses. After sonication, a final spin at 1300g was completed to 
remove un-broken nuclei, and the supernatant was collected as the nuclear fraction. 
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GAPDH was used as a marker for cytoplasmic fractions and phosphorylated RNA Pol II 
was used as a marker for the nuclear fractions. 
Immunostaining 
Mouse embryonic stem cells were grown on gelatin-coated tissue-culture treated 
plates and transferred to slides and fixed for 15 minutes in 4% paraformaldehyde in PBS. 
Immunofluorescence staining was performed with standard protocols using an Alexa 
Fluor 488 conjugated rabbit anti-mouse secondary antibody. A 1:1000 dilution of DAPI 
was incubated with fixed cells after staining to label the nuclei. Images were taken with a 
Leica TCS SP5 Spectral Confocal Microscope in the sequential scanning mode. 
Knockout Mouse Generation and Mouse Husbandry 
Conditional Puml and Pum2 knockout mice were generated in collaboration with 
the University of Connecticut Gene Targeting and Transfer Facility in Farmington, CT. 
Puml Flox/+ and Pum2 Flox/+ mice were each mated with EHa-Cre mice, which express 
Cre recombinase under the promoter of the Ella adenovirus gene which is expressed 
early in development. Mice in which the floxed Puml or Pum2 allele was excised were 
confirmed by genotyping, and all subsequent crosses were performed on global Puml/2 
heterozygous mice in the absence of Cre. 
Genotyping 
Tails were clipped at 21 dpp and digested overnight at 55 degrees with Proteinase 
K. Genotyping samples were diluted 1:10 with distilled water and 2 uL of each sample 
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was used as template for PCR. The following genotyping primers were used for 
genotyping Puml and Pum2: 
Puml: Lox gtF: 5'-atcaggttgccagtttcacc, Lox gtR: 5'-ttttcactgaaccagcaagg, Frt gtR: 5'-
tgattctgcaaggacagcac , Pum2: Lox gtF: 5'-CATACTGTCACTAACCTGTC Lox gtR: 
5' T GCTG ATCT CAT CTT CGG AG, Frt gtR: 5' - AT GC AT AT GTGCC AT GGAGC 
Cre internal control primers: Fwd: CTA GGC CAC AGA ATT GAA AGA TCT, Rev: 
GTA GGT GGA AAT TCT AGC ATC ATC C , Cre primers Fwd: GCG GTC TGG 
CAG TAA AAA CTA TC, Rev: GTG AAA CAG CAT TGC TGT CAC TT 
Nested PCR for Genotyping Blastocysts 
Two rounds of PCR were performed for genotyping blastocysts. DNA was 
isolated from blastocysts using the QIAamp Investigator Kit (Qiagen), eluting in 23 uL of 
nuclease-free water. 10 uL of this DNA was used for each PCR. The following primer 
pairs were used for Round 1 and Round 2 reactions for Puml and Pum2: 
Nested PCR primers for WT PUM1 Round 1: 
A)TGAACTTGGCTGTTGATGGGTCCG 
B)TCCATAGACTGGTCCTCTGTCTCACCT 
For KO Puml Round 1: 
C)tgaacttggctgttgatgggtccg 
D)agggtgtggccttttggccttt 




For KO Pum2 Round 1: 
K)ggtttccttgctctttagtcttcccca 
L)accatgctccaaagtcccacgg 
For WT Puml Round 2: 
E)T gaacaggtgaattgctgactgtgaa 
F)Cctggctttgggagtttcagggc 
For Puml KO Round 2: 
G)T gaacaggtgaattgctgactgtgaa 
H)Agggtgtggccttttggcct 
For WT Pum2 Round 2: 
M)tgcttttgttcatggttttctg 
N)gcatgctgatctcatcttcg 
For Pum2 KO Round 2: 
0)tgcttttgttcatggttttctg 
P)ctgcttccacttttgcatga 
Transfection and siRNA Knockdown 
Cells were transfected with Lipofectamine 2000 at a ratio of 1.5 uL 
Lipofectamine to 5 uG DNA to 45 uL OptiMEM. Reverse transfections were performed 
in order to maximize transfection efficiency, and repeat transfections were performed on 
Day 2 and 4 for Cre-mediated excision of floxed alleles. siRNA transfections were 
performed according to the same protocol, and were repeated 48 hours after the first 
transfection for increased knockdown efficiency. Puml siRNA (Dharmacon Smart 
108 
POOL) contained a 5nmole mixture of 4 different siRNA sequences. Non-silencing 
siRNA (scrambled) was used as a control for all siRNA experiments. 
Histological Analysis of Tissues and Embryos 
Organs for histologic analysis were fixed in Bouin's solution overnight and 
serially dehydrated into a methanol solution. Bone samples were demineralized prior to 
staining. Hematoxylin and eosin staining was performed per normal protocol by the Yale 
Research Pathology Department. For the intestinal analysis in Puml -/- mice, measured 
sections were taken from the stomach to quantify duodenal, jejunal, and ileul regions of 
the small intestine. Embryos were dissected from uteri in cold PBS + 0.1% BSA. Yolk 
sacs were dissected and utilized for genotyping as previously described, and embryos 
were fixed in 4% PFA at 4 degrees overnight. 
RNA-Immunoprecipitation-Microarray (RlP-Chip) 
Mouse ES cells were lysed in cold MLB buffer (150mM NaCl, 0.1% NP-40, 
0.1% Triton-X, ph 7.4) with IX complete mini EDTA-free protease inhibitor cocktail 
(Roche). Total cellular lysate was spun at 10,000 RPM for 15 minutes, and supernatants 
were used for all subsequent experiments. The total lysate was pre-cleared with 
equilibrated Protein A Sepharose beads (GE Healthcare) for 2 hours at 4 degrees. Pre-
cleared lysate was added to primary antibody for 4-6 hours at 4 degrees, and then Protein 
A beads were added and nutated at 4 degrees for an additional 2 hours. RNA was 
isolated directly from the beads using Trizol, and was further purified using a QIAquick 
kit (Qiagen). Samples were reverse transcribed and analyzed by qRT-PCR for 
enrichment of Cyclin Bl, and submitted to the Yale Keck Microarray Facility for 
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amplification and hybridiazation to an Illumina mouse Ref v2 BeadChip array. 
Experiments were conducted in triplicate, and a negative control using blocking peptide 
against which the antibody was raised was used for the normalization of all data. 
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129 47 0.387 
1.27 02 0.34 MuBmuscuUadfiBladiniyrfliocytcraukfmU. 
1.2 321 0.26 Mus miscuks DEAD (Aip-Gb^AJa.Aap) t»oic 
1.20 104 0.331 
1.20 ICS 0.323 Mus museums mrrnrptkn factor 7-lte 2. f-cel 
1.2? 74 0.3*9 PREDICTED'Mus murajlgosmilar to T-bo«, 3 
1.3* 25 0.388 PREDICTED Mue iruecul* DNA e^gr-siit, Ch? 
129 43 0:37 PREDICTED Mue iweeukie perf)^>«pocjfi£ 
1.32 21 0305 
1.27 90 0.341 Mus muscuUs LYEJFlAiJR domain cantoning G 
1.23 55 0.302 Mus rnuscufcs expressed soqjcrce C7GGCC 
1.3 29 0.303 Mus rrii5cu\i3Tamme ii*ciw? prcte^t 100 
1.29 52 0.364 
1.2 322 0.259 
1 20 65 0,356 Mue mueeufcs rinen (KJnK tran&erttfl 1, 
1.29 4A 0.3G5 MUB muscuVs safcaifc* horrclag 1 (Drasophlal 
1.«5 639 0.204 Mus fnuscufcs ocpiln 1 tela |Map1b), mRMA. 
1.22 223 0.2B4 PREDICTED: Mus rruscutuo zinc lluer protein 
1.23 173 0.304 Mus musculn; prawn fTw3p"efc35fl 1, regulator/ 
1.2S 110 0.327 
1 25 t22 0.321 
1 te 597 0.216 MIJB ntueetiita Enositsfi 3,3,4&&-
1.24 135 0,315 MUB mu&cufca «fsftrtnA1 (Etnal J, mRMA. 
1.20 44 0.37 Mus rnuscutis CTO (GartKuy»taTT»nal domain, 
1.23 197 0.293 Mus rruscufcs tarihoad bo« J3 |FokP), rrRNA. 
1.27 91 0.341 Mus ntuscufca RiKEN cOK* «931406!20 gene 
1.22 204 0.292 Mus museums OMA se^nem, Cfr 5. WBJT:© 
1.«9 354 0.253 
120 72 0.352 MuentueciiUflRKEN«OK!A C030046E11 gane 
1.27 FIS 0.342 MUB NUI&CULS C^QDFTIASM'C TJRTOCNA Mnasa, 
1.28 62 0.33 Mus truscuLs AT Ixcfc, DMA. tjWlr»g mall 
1.24 141 0.313 Mus rr.uscufcs tour lotted tea 1 iDrosaptrfti) 
1.2B 95 0.339 Mus rruwuta Z»K frgerprcteh>S-irfcsd(2(ID. 
1.2* 139 0.314 MusrnuscuXsn RiKENtOWA ES230317C12gene 
1.20 0.350 Mus iruecuV«rij»-54 homoteg (C eleg^nej 
1 24 140 0.313 Mue rru&cuUfl (*oKin flhoGpftitam 1. r^uUtofy 
1.27 73 0.35 PREDATED Mus iruscuLa zinc flrqat protein 
1.27 OS 0.341 PREDICTED: Mus rruscuta zinc ttigar protein 
112 
1G9 KSflb aC017eS 1179 1.23 33 0.373 MusrcuKUlkS&frKSIHamtfmanfccf IB (KCIbX 
110 Rapg l̂l 0,001741 1172 1.23 *0 0.372 Mus rruscufes Rap guaruie nucleotide enchants 
111 AWaOatt) OCU1251 mi 1.2fl 0.302 Mus nruscutoB expressed soqvirce AJastlblO 
112 «3&i26Ga 0 C01097 852 1.28 «7 0.355 Mus rruecuVa RKEN cOKA <&XM28G20 gem 
113 Cds? 1,0*1-05 12 1.S4 7*6 0.105 Muerruseul̂ eel dw^en cyde 7 <S 
114 Rndi OCOOB38 630 127 7Q 0.345 Mus rr.uscuVs RAOI homdog $S- pomba) 
11S 2210419D2 O.C00124 113 1.22 232 0.2B1 
116 Bfacnn D.00096 713 1.27 76 0.3*5 Mus rr.usculis cufcaryctl:. Irandalioo MlbDan 
117 Ck2 0.00153 1C7I 1.29 S3 0.3C3 Mus rrusculus CDClkj« knas© 2 (CU2j. rrRNA. 
118 &Jf2 0000349 3.TS0 1.24 iss 0.314 Mus rruscufcs sufataso 2 (SuttJ. r-RfCA. 
119 Ube2g1 0000247 227 1.23 180 0.302 MUB rrureuto ̂ QIIIN-CCIIMJAIRG OIIIYRO 
1» giri 0000174 154 122 211 0 29 Mue irueeuVs E74-lke 1 (E/8) mRNA. 
121 5033-403^1 5.20E-Q5 61 1 49 393 0.249 
122 Actp2 aC00222 262 1.24 161 0.3Do Mu& muscufcs A£ bnd*"fl protoh 2 fAxibaZI, 
123 291CMB5I05 Q.G00352 320 1.24 1*8 0.31 Mus rrusculis RKEN cCfvA 291MB5I35 genu 
124 ctro2 O.GO05M 400 1.20 112 0.325 Mus rrusculus strawberry notch norr.otog 2 
1» SpotalS 2.2BE-05 2? 1.B0 595 0.2 IS 
128 '/a«3 0000114 110 1.21 269 0.271 Mus rrueeuVe"*  ̂3 oncogens (VawSl, irsitscifcM 
1*7 LOCtOOMS 6J1E-05 75 1 38 m 0,252 PREDICTED Mue rueeuto timUr 
128 T«*ttl1 QC00237 265 123 175 0.303 MUB muicuks M'U gana TARAKOG 1 (DroaopTiUi 
129 RmndEb Q.B01 105 es? 1.27 7S 0.345 MUE muscuks RO^JROD far moucllc nudoar 
130 CorojJ 0,001936 12E2 1.2B €1 0.3G1 
131 Iwslatp a00u377 347 1.24 139 0.3U7 Mus museums inibenza vnn NtJlA Dromg 
132 «3£M26M1 0000338 304 1.23 177 0.303 Mus muscuto RKEN cOfCA 4933426M11 aono 
m Nealn 0OOO3S8 339 124 16? ft.305 MUB RRUTCU^E nesolm (Nsswj. ffrtRjpsiA. 
134 S»2 0 000524 441 125 133 0,917 Mus rrueeuUft SRY-bo«. <awcsirtn(j tjtrv 2 
115 Pf/13 aooo«37 265 1,24 ISO (X307 Muc nuiECuliS PHO filler preocin 13(Ptif13S 
136 RSQS aC00S32 677 1.25 116 0.324 Muc rrusculus plotfcstrln iKrrciagy, Scc7 and 
137 WViEa 4.45E43S B 1/61 1315 0.1*5 Musir.uscuti5v4n(Tcsscrtcralod(^741V 
138 LOCCOOWl 0.C01113 880 1.28 93 0.333 PREDICT tD: Mus irusculua hypolrtetoral proorin 
139 Nudtf 0000141 130 1.2 27* 0.289 Mus rrutcuto n j r iU ,  (rudooy^o dp^Knpiote 
140 lrf» 0 000275 251 1.22 207 0,282 Mus rrueeu^e tnieifercn raQUWoiy t«l»f 1 
141 Rk3e3 0 000544 460 1 24 137 03H Mue mueeuka ̂ *«<3#,»5iJ»9Bd&-34inflw, class 
142 Seedta aCQQSS7 489 1.25 131 0,317 MUB MUICUKS SET dorain ccnlarlrg 1A 
143 mOIMA^ND CiOQDSI £63 1.25 111 0.327 
144 RbmS ~ aCOOKE 4S8 1.2G 132 0.317 Musrrusculcs RHft binding TdH protein 3 
145 f-mnO 8.07E-05 77 l.tiO 429 0.241 Mus muscuUs tomfn«lke 3 (Fmrf3X mRNA. 
148 PV-*11b OQOOTOS S88 1.29 121 0.322 Mus rruocuto pwnnom-  ̂begonenb fortor 
14? Cigf 0001403 1011 12? 60 0.344 Mue rrueeuVe connecJwe i««8 g*o*fr teeter 
148 493CS39E0 0000741 630 125 119 0,322 MUB museuta) RKEN t£KA 493OS39E06 gane 
149 Gsl3a 0iC0023S 213 1.22 225 0.2B4 MUB muscuUs ̂ yco^sn s>nlhaia Unasa 3 ̂ Jpna 
150 Ap2a2 aooosco 277 1.23 203 0.293 MUE rruiculiS ATPAIC. CA  ̂U-JNIPORING, 
151 FttcMol 0.00005 3BD 1.23 170 0.304 Mus rruscutis pnc»Je tao 1 (DrosapMb) 
152 Pall O.C01S14 1C82 1.2? 77 0.345 Mus muKuKta F.AT timor supjirrscor harrclog 1 
1» CM 0000124 110 1.2 320 0.28 Mus rruocuiua C&C tfts bnne * (CFI4X mRNA, 
154 Unci10 9.08E-05 70 1J>0 4«3 0.234 Mue rru«yjV>e wne-H9 hemoioo (C «ie^«e} 
1S5 Pi rin 0000352 33i 129 193 0,295 Mue mueeuWa C îdn (Pttty rrRKA, 
156 HTYSM QG01541 10(73 1.27 ai 0.344 MUB mu&culd ayb-lhal SWFtA and »N 
157 M;I3 0.002051 1203 1.2B 69 0.353 Mus rcuscufcs arycCatdl̂ inpnad or muod-
158 Splrrtl 1.92&05 21 l.ftfl 778 0.192 Mus musculis sortne F<oeeas« Inn bRor, KunCz 
139 Vfcorclll Q.QOQKM 800 1.24 146 0.312 Mus rruscuVs wRan-in K. epo.»J^9 rwJudase 
180 Gao6 0000716 587 1.2S 139 0.317 Mus rnuscuta arrest epecfic 0 |Gaa8K 
161 Cefli# 00030S6 1638 1.29 49 0.385 
162 Se«21 000133J ®7B 1 26 67 0939 Muc muKiilu) SRV-boa. oort^nng gw 21 
163 DaH2lp 0iD0Q39 255 1.23 193 0.29S MUB MUSEUMS D&AFCTOD Ircm&Cog 2 {DRDFIDPTTCA) 
164 Purr2 a002G54 1555 1.2B 63 0.359 Mus musculo pun Ha 2 (Dnasophla  ̂|Pum2|, 
113 
165 £ptrQ2 0.002D39 1547 1.2B 
166 Raogeft 0.0014M 1002 1.2G 
1«7 6030M300 0000626 520 1.24 
1« Btgl 0.000% 772 1.25 
1«» sm2 0000175 158 lc2 
170 rmOMAMD Q0032SS 1771 1 29 
171 Vtozll aooom 108 1.19 
172 G330G14E2 Q.000415 370 1.23 
173 FW13 0.000395 337 1.23 
174 231CO05N0 7.29E-06 10 1.11 
175 -An>d2c 0000101 102 1.S0 
17« B230317C1 O.OOK m 124 
177 111C0Q1A0 0 002152 1339 127 
178 MG£M 0.000535 S70 1.24 
179 383GG12M2 0.000977 761 1.2G 
180 O.OOtHi 390 1.23 
181 B230339VO 0.00046 400 1.23 
1«3 LOCiOOtM4 0001618 1110 1.20 
1*3 KcJd15 &Q3E-Q5 57 1 10 
184 write a0015S7 1068 126 
1&S 5l£30a5 (X00045 233 1.23 
-186 Grarrdlb 0 001978 12G2 1.27 
187 9c3Sa2 0.002BK 1637 1.20 
188 1200055N2 0.00012 119 1.10 
189 9M7b 0001865 1221 1.20 
190 Ulp24 0000172 153 1 10 
1»1 mffiNA_ND a001047 817 1,25 
192 573CM0SI39 aOOQ257 2GB 1.21 
193 Bzntpt 0.000216 193 1.2 
194 Pptn7 Q.000S47 040 1.23 
195 91304S5E2 2.46E-W 20 1.(4 
1M Hl̂ » 0001259 9<30 1.25 
1®7 &QI* 000114 670 125 
196 2lpS32 Q000917 667 1,24 
199 Ensa 0.000247 22G 1.2 
200 Zip 12 0.000267 242 1.21 
201 McrS aouoem 033 1.23 
292 RbiTrfb 1.24E-05 13 1.52 
W3 Srnie 7t84E-« 01 1.17 
1&4 stcssete 5JOE-OS 67 1 16 
7&S Ilt2 aooosza 444 1,22 
286 DojKtclb B.3DE-05 B8 1.17 
297 Ec<dlb 0.001G41 1123 1.2G 









8.30EO5 07 1.17 
210 FIIWQ 0000065 715 124 
211 Pperd 5 87E-05 69 1 10 
212 2Tp131 5.1GE^B 59 1.15 
213 241C042D2 1.GOE-OS 19 1.12 
214 SE«12 0,000331 268 1.2 
215 H-J2 1.41E-05 10 1.12 
218 Rbn»5 0 000917 751 1.24 
21? Tftl 0000422 374 121 
218 S îl 2J5E-05 31 1 13 
219 Get 0.00131 564 1.25 
220 ao40a1 a 00 W13 2457 1.21 
64 0.359 Mus musculo zpta homoiog 2 IDrccapMUl 
94 0.339 Mus musculis RAfi QuarJns nudetiliOc 
1*9 0.31 Mus muscuVjo RIKEN cOffA 6030443007 Qam 
113 0.324 MUB muecuto B-c«l liBiiiJocaifcn gang 1, enti-
293 0,288 Mu$muecu1j« SET rtoriisin wma'ning 2 (3eid2|. 
51 &3B4 
373 0.25 Mus mu&cuViS vaicutir ondootdial 2lnc firmer 1 
197 0.295 
201 0.293 MusmuscutesPKDftî ef protein 13(Ptitl3K 
124? O.lS MusmuEcutra RIKEN cOfA 2310005N01 srne 
402 0.2*S Mus muewrtie |umcv <jQmen OQnOfring 20 
163 0.909 MuemufOiUS RKEN <Ot*A B73O317C12g9O0 
75 0i,343 MIIB musculo RttEN cDt«A 111CQ01A07 gana 
153 0.3DO Muc musculo metlLaXf ci RN!A prfswecaso B 
123 0.321 
199 0.294 
198 0.205 MUE muocuVra R&GN cOffA &230339V06 GERW 
99 0.338 PREDICTED Mue rrueeuto ®«rotar to frodulsior 
571 0.217 MUA MTIE&RIJE PET883»IJN CNWNEL 
OB 0,335 MUB nwscults dlnoafr fnmty mannfasf 1SA 
202 0.293 Mus musculis solute canter tartly 30 (zinc 
as 0.342 Mua musculu-s GRAM fit man oortnWntj IB 
65 0.3G3 Mus musculis solute canter tartly 3&.mentiKT 2 
398 0.2*6 Mus murcutjo RKEN cOf*A 120OO1SN2O gene 




303 0.2G4 Mus muscuba benzoiazapho rcocptef 
1fl3 0.302 Mus museums PTC? protetn phosphatase 
023 0.107 
117 0,324 Mue rmiecu\rti*meiopc»eiis«fl)fetpr«iMO 
124 0,32 MUB MUGCUBE SNF2 htilonn PHD RIMO 
152 Q.3D9 MUB mu&cul*s zinc linger proialn £32 |Zfp632  ̂
233 0.2G9 Muc musculis erifoaJfiio a\ptia (EnsaX 
275 0.27 Mus museums zlre; thgar proteh 12 |23p12). 
\X 0.299 Mus musculis rr»~xy>mi Irvijclco eorty 
1149 0.16 Mus musculie R^tA binding irctH proGsin 48 
505 (X226 Mue muecuUe sorting resit 16 <Sn«iej. mftNA,, 
567 0.214 Mue mueeuWs aoU« cantor Urrily 2S 
208 0.232 MUB muscuUs iniarfaron-lf*ljcod pnxsin vuitn 
500 0.227 Mus musculis DEP domain contain*  ̂1B 
109 0.329 Mus museums SET domain ecfllanlftg IB 
143 0.313 Mus musculiBFnioowhaclwalsclprotetnhrtKa 
512 0.226 PREDICTED Muo rruscukjn 54 rn tar to 
164 0.308 Mus muscu*j« krrriiHke 2 (FntfWX mRNA. 
615 0,212 MuBmu6aib8p#<ui90ff»p«ll&»«WMtotfacr 
643 0.207 MUB mutculaa zinc fftgar protatt 131 |ZTp131K 
1099 0.1D4 Mus muscubs RKEN cCNA 241C042021 geno 
279 0.2G9 
1155 0.199 Mus musculn heat drxA factor 2 (Hsf2X 
165 0.305 Mue muocuta RMA brrirtg rrolit prdtein 5 
245 0.278 Mus roueeul*e toue^d-lfce *in»e 1 (Tblji 
679 0, >B2 Mus rmi&cuVifl shngwhivlfcA 1 <S .pe*nb6) 
134 0.316 Mub musculo c^uUnWa-cyslanQlkpsQ, 
248 0.277 Mus muscuUs solute canter tartly 40 (irov 
114 
221 Sfe25 a000252 210 
2Z2 Sdc3 2.7 CEO* 30 
223 &>d:2 0000343 30/ 
224 Sett. 0002271 1302 
2» Settib2 QC00569 477 
226 Cd»2 2.00E-05 26 
227 Carrca2 acoosas 452 
228 Ub^na 3.BOE-OS 42 
229 Gnl3 a000667 800 
230 07*5*1 O000592 482 
231 201090610 0001863 1210 
213 ClBfHpll 0801094 W 
233 Fnipl aC00M6 701 
234 F(fio2 0.002272 1294 
215 Spredl 0.0002M 232 
236 Arkrd39 O.OOOQ1S 570 
217 BapD S.56E-05 66 
2» wipra 0000212 ISO 
*10 Tf0*i2 0000223 200 
240 Kfll OC001G7 173 
241 TmamSb acoo&57 475 
242 E<h«>1 aD005E4 471 
243 Mram O.GUUUS eofl 
244 DuspS 3.04EOS 40 
244 Tm«ni53 0000451 S97 
246 Bfcc9 0 00U24 1017 
247 Poll 4.61E-OS SO 
248 F739314I05 IX0D074 618 
249 Cafe 126 O.COOM4 459 
250 Tm9sf2 O. GUI 2*02 SOB 
2 VI Ciro2 0 GO1206 918 
252 2Tp2»B 000023S 212 
253 C7«?67 0000(03 670 
254 170C047I17 O.C02059 1672 









 O.DQ07S2 613 
257 SrrcB a0013!»7 sea 
2» ND11 0.00074 610 
250 a«42c#»i 000024 218 
260 LCC1S00047 3.8PF-05 44 
261 ugig aC01005 SSO 
262 Erpll B.7GE-05 32 
263 UspCnl 0.000346 311 
264 Stp2 o.ou&ra ew 
265 Es*S ooooToe 56? 
266 0000711 $03 
267 UfttSb 0000175 163 
«3 Gtpdp2 a000224 £01 
269 Tore a000395 3C0 
270 fiOip B.74&4J5 91 
271 Ubc2a 0.000674 eao 
272 2810103AQ 0000*25 37 S 
273 TeoM 0000623 526 
274 I
 I O000162 143 
275 Ra&11b 5.33E-OS 64 
276 Rmap$>1 a000346 312 
1.13 334 0.257 Mus musculo 5PC25, POCSO Lnolortiora 
1.13 031 O.ia Mus musculis symecait 3 (Sdc3), mRNA. 
1.21 2/t> 0.2? Mus muscu'ua crw dcrran corns ri ng 2 l&nic2j. 
1.20 101 0.334 
1 22 214 0,267 Mu$ ir.ueeutje SET dom£n, bfurewad 2 
1,12 1023 0,17 MUB musculis cycln-dapar«San! Unasa 2 {Cdl?), 
1.22 222 0.285 Mus musculis calrcodufn bndng iranscflpfton 
1.14 784 0.191 Mus musculis t£4qiiln 4 (Ubq"tv4X mRNA. 
1.22 239 0.291 Mus musculis gjanhe nuboolde bndrg 
1.22 217 0.206 Mus rruscutrs expressed 3cq^?rc« C7ftS08 
1.25 114 0.324 
1 24 1® 0.908 PREDICTED Mue mi&eube Cflii, cran-pod-lk# 
1.23 191 0.207 MUB mutculis fcilaJft Imeraellrg protaft 1 
1.2B 107 0.33 Mus musculo FCH domain cmif 2 |Fcha2|, 
1.49 341 0.2QG 
1.23 19!) 0.295 Mus musculis arfcwn repeal demon 39 
us m 0.2 
1,58 392 0,247 PREDICTED Mue rryecuUt WASV/ASL 
1 10 385 0.2*8 Mij6friife»i*i»*Bn'iSwgpre<i1i^Jk«W(«"n bitriang 
1.18 417 0,243 MUB RRUIBCUK9&LNEAIIRAML^MAITEER 11 (KT111), 
1.21 241 0.279 MUE musculo transmantrano prctaft 5G0 
1.21 212 0.279 Mus musculo scfw.anncrrin irtcracing prolan I 
1.22 &»S 0.291 Mus musculis melanoma cell adhnnn motectfe 
1.53 096 0.101 Mus mutsulis dual spootay pfcoephatas© 0 
1.21 274 0.27 Mus mutPSuto frBirsin&nferfrw pro4qh 60 
1.24 1 54 0.309 Mue musculrt Be3-2 Wntfng eampe«*snl 3 
1.54 813 MBfl MUB musculo {prolan as&ocbuadwm 
1.22 21S 0.283 MUE musculo RKEN cDfCA F730314I05 gena 
1.21 252 0.27G Mus musculis cafodiooll daman oottlaNng 126 
1.23 131 0.302 Mus musculis rammcmbrons a supeifamty 
1.23 102 0.302 Mus murculia eolat^rshmwt erf ocbet?on 1 
1.50 3W 0=2^0 PRE0CTED Mue rriiscukje iincrrgyrpretein 
1 22 212 0.2B9 
1.26 1Q3 0,331 MUB muscuUs RIKEN cOfCA 170C047I17 gana 1 
1.2G 105 0.331 MUE musculo *attcatrg prctoln parti do ccmpfox 
1.22 227 0.2B3 
1.23 171 0.304 Mus musculis struct  ̂martenonce <rt 
1.22 226 0.283 Mus musculo m«roeprt*!lal «l transforming 
1,b8 410 0*244 Mus mueeuliS supp'wsaj* ol 4-20 
1 S3 010 0 178 PREDICTED Mue mjftcjikjfl rrypor l̂icfll frQU+n 
1.23 194 0.208 MUB iraitculiS UDP-̂ UOON coramdo 
1.15 645 0.207 MUE musculis trcrnadoma n and PHD Ungor 
1.19 339 0.2HS Mus musculis USPG N=tnrm*\jl Efto pspSrtfc 
1.22 216 0.20s Mus musculis seawotnizVw-reaied pnmin 2 
1.21 2S6 0.28 Mus musculo tfa vwiorrl prro 5 (Et*3X mRNA. 
1.21 2$9 0.28 Mus muecufce rmr& fetjpjrgor e»HI 8V8WW, 
117 4SQ 0,231 Mue fPu&CJiiifl wc-5 ha-rc4og B (C eleganc) 
1.18 43Q 0.239 MUB musculo OTP bfrdftg prorata 2 (Qipsp2), 
1.2 335 0.259 Mus musculis TAF5RMA pa Vmcraso II, TATA 
1.15 1X2 0.205 Mus musculis ocir/ty^dcfKFtfcnl 
1.21 250 0.277 Mus musculis ubiqutixunitsgalrg enzyme 
1.2 318 0.26 Mus musculo RiKON cOfvA 201O1O3AO7 gene 
1.21 260 0.27< MuS musculo TAQ UnaiU 1 (TaoM). raRNAb 
117 511 0.22fi Mus rriiwculifi irwphBifl-pfwoing ocrrpkau 
1.14 851 0.1B5 MUB rruscuUs RABt 1B, mantxir RAS arcogcro 
1.10 >39 0.251 Mus musculis FroSAPIPl protein (PttaapplX 
115 
Z77 Chc2 0CQ2329 1212 1.24 144 D.313 
Z7B Tnm59 0.00011 107 1.10 C23 0.21 Mus muscufcs traralc moOI<oortaHng 
279 Dad2 0000205 166 1.1? 473 0.233 Mus mucculra CLAV (er-fcryo*tc lelhrf. 
2*0 VfcorclH 0001432 1020 1.23 185 0,3 Mus muecuto vttjrrin K epo<i<fo redo ctsue 
»i LOCIOOJMS 8 43E-05 69 115 701 0 2 PRFDCTFD Mue mieetita hypofwieiM {*&&(* 
232 170C054N0 a000404 364 1,19 333 0.256 Muc musculo RKEN cDNA 170C054N0S $>na 
223 AM BOG 5 3 4.35E-05 4B 1.13 044 0.176 Muc museums caprascod soquanco A14B05S3 
224 FbH045 aooai2t 2BG 1.13 391 0.247 Mus musculus F'baic protein 46 (f%HD45|. 
215 Damtd4 0.001875 1227 1.24 157 0.309 Mus musculis OCNl. defective in cuin 
2U Wf? l.SSE-05 10 1.1 1*24 0.136 
2»? UncllO 0000239 261 1. «6 420 0.242 Mus muecuta wx-i ifi hrxnotej (C elegsnel 
M3 F63D043A0 0 000277 254 1 18 427 0.241 Mue mueeuliS RKEN <OKA F630043A04 &nd 
239 BCC3 0001772 1182 1 23 169 0.304 MUD mu&cutis Bci-2 btndng comportanl 3 
290 LOC2tGD53 O.OOOS73 E6G 1.21 263 0.271 
291 A1SIJ12 01000776 643 1.21 251 0.276 Mus musculo AOP nboy^aiton laarx-Uj? c 
292 EOJOOfctMl 0.002255 1370 1.24 147 0.311 
293 Nosln ©000*2? 3/0 1.19 344 0.265 Mus musculis ncastnn (Nassij, rri^WA. 




1 00001G9 150 1 17 533 0222 Mue mueeiiVjS inftan^t viva NS1A finding 
236 Deunld* Q001071 336 1.22 216 0,288 Muc muccuUs OOJ1C cfiaracilwa In culirt 
297 Rns3B 0.0010S7 B2B 1.22 220 0.2B5 Muc musculis ennaaso. SQrtrtt, 3G |Pres3D), 
290 Irab2 0.00035 317 1.13 334 0.247 
299 Am2 0.00036$ 301 l.tB 37$ 0.25 Mus musculo AT nclt interactive daman 2 (AHd-
«0 Btgl 0001081 643 1.22 219 0.205 Mus murculra &-cal Irani-loealion gone 1. onli-
m Pre»1 0000225 205 1,17 462 0.231 Mue muwuVra creiiip%nlelofi ptolen 4 iPmM). 
sea 0003419 1612 135 119 0.324 Mue mueeutue ADP-tfimjteiten fecasr-iu 8A 
soa FW2 Q002&S3 1560 1.24 133 0,315 Muc muccuUa PHD fjnctxdn 12(Ptiri2K 
294 Tbfcl 0.001769 11B1 1.23 1S4 0.301 Mus musculo TAN&Undnp IJruKO 1 <Tbfc1), 
J9S 231004OA 1 01000557 4GB 1.2 312 0.2G1 
586 B0020023 D.21E-0-I as 1.12 11S9 0.159 Mus musculo cONA sequence QC02Q524 
397 Sok2 00010S5 82S 1.22 224 0.203 
308 Duip8 0 000521 439 1.2 325 0.258 MUB mueeuto drtl specific^ c*oec*et8&9 8 
309 G«2 0 001031 791 1:21 233 0.281 Mue muecuUa Gll-Knjpp«! ram't^ mervfc«r OLt2 
310 FmnD a000* 53 403 1.13 34a 0.254 MUB rmiscuits fcrrrinJka 3 (Fmrt3)i mRNA. 
311 SC^Q a 001042 12SS 1.23 176 0.303 MUB musculo squfano cpct&daso (6qk»), 
312 TICS 0,000351 31B 1.1B 409 0.244 Mus musculis tetnm&apcptkte repeat domain 6 
313 faofcl 0.0001£2 13/ 1.1/ 642 0.221 Mus muscu'uo TAO kanoje 1 iTachlj, rr^tNA. 
114 Fnpl 0 OOOEMi 54! 1.2 302 0.265 Mus musculia MioJn prcloh 1 
3ii U«>1 0000323 260 1,18 423 02*1 Mue muwube vtrfqutr eptcrtc pspide&e 1 
31® llgt>1bpt 0000449 332 1 VXIO 0.252 MuemueculMHile^irtbQlB 1 bindng prolan 1 
317 3S3D431G2 aooosia 43B 1.19 333 0.257 PREDICTED Mus rruscuba RIKEN QDNA 
313 CLD00227 207 1.17 433 0.227 Muc musculis LSM14 hcoiolcg B <S<3>3. S. 
319 Cbln3 O.OOOD57 664 1.2 293 0.2G5 Mus musculo cabplnnn 3 |Clstn3X mRNA. 
330 Oaaml 0.000373 343 1.10 407 0.244 Mus musculis d^*eve4M assoclBlsd ackvafior 
*21 dtc3 0003649 1677 1.2S 120 0.322 Mus muscula Bd-2 fain^ng campcment 3 
372 5*1 0 002579 1518 124 150 0.31 MUB rru«ul>6 SKMi^ <S*tl)L trflnecrip! 2, 
323 AU»2 000046 407 119 372 0 25 Mue mu&culis «uivn eusupiKiity csrvSlddca 2 
324 Dusp4 a000163 145 1.16 605 0.214 
12S LOCGGB4S2 a002503 1632 1.24 151 0.31 PRH3KTTED; Mus rrusculus slfrtlar to 2hc 
326 G03044300 0.001034 611 1.21 243 0.276 Mus musculis RKEN cOfSA 0030443007 gore 
327 C7940? O.OOOC2 01? 1.2 317 0.26 Mus musculjB mpressed aeqwrroe C79407 
*2* Msxfcstl 0 000214 I9i 1.1? 532 0.223 Mus rmisculia &NABCKS-fi*» 1 )Mon#iril)i 
m CBJ<J10 0 000175 159 1 *8 5ft3 0.215 MUB rwvilwtfnl Oom^in 
330 Cbfc 0 000175 158 116 591 0.215 Mue muficuWfl eora billing fnesot ton fca/b) 
331 Gp/23 4.65E-Q5 51 1.12 1051 0.167 Muc miiccuUai G prolaJvcou^odxntflplor 23 
332 RBI1 0i003&55 1B7D 1.20 125 0.32 Mus musculo rnUiobUslcfT^llio 1 <p107] 
116 
ua C«11St1 0,000773 645 1.2 299 0.207 Mus musculis CWFlWfco 1, col eydo conlml 
334 NcapflZ 0.00093 7B4 1.21 2M 0.275 Mus musculis noc^SMC ccfldciwtn S arpptei, 
us Ube2g1 0 000&9C 361 1.2 395 0.263 Mus musculo Ubijylj^coryjijalrg crczy-TW 
»4 Brpll 0000239 260 1,87 m 0.232 Mus rrutcu»i8 crcrnMomsn and PhD 
»7 Rene 0000677 728 121 272 0 27 Mue mueeufca ptfilerinno «l nutl«r enSgftfi 
233 Asgffo 3.77E-05 41 1-11 1173 0.157 Mue muuutis ATG2 ajupnng/ reura 2 
SJ3 RJM 0000719 COO 1.2 303 0.2G3 Mus musculo enncin t>TOsno phospiueaso, 
340 C130CC-0N1 OOQ24S3 1474 1.24 ICS 0.305 
341 .rtrtla 0.00013 424 1.10 370 0.249 Mus musculis ACP^nbos^falton facODr^lte 4A 
M2 Sfel 0000792 est 1.2 297 0.265 Mus musculin sta sarcoma vml cnro«jene 
J43 Spj'j9 0000512 435 1J0 374 0.25 Mus apoun tuacKiveO efriyoo 9 
344 Wbtf ooooesa S75 1.2 315 0:26 Mue mueeulrt WN <Jirre*i birrfng protein 7 
345 Puml 0002B14 1623 1 24 153 0.3B9 
346 ESv5 oooosas 730 1.2 290 0.2B9 
347 DaH2p IX00054 4GG 1.13 370 0.251 
348 Hm^b2)1 0,0017« 1100 1.22 205 0.292 Mus musculis Hgh motor? group Cow 2«»te t 
J49 CBT^I 0.00065 549 1.2 321 0.2S3 Mus rruscu\ra conlromere pxrfcw 1 |Conp>), 
IW Nef 0000157 Ml 1,ci5 050 (K207 Mue mueeuto naee® embryonic LHRH Isdor 
SSI VV43 QC02512 1404 1:23 174 0.303 Mue rrueeiiVis V*D repaei darato 3 (Wdifi), 
352 U Cft 13 3.10E-Q5 33 1.11 1273 0.143 
353 23icmoco 0002502 147B 1.23 173 0.303 Mus musculis RIKEN cGfCA 231C©&GC03 geno 
354 DG30C23F1 O.C01-495 1GG0 1.22 221 0.205 Mus musculis RIKEN cCKA OG33G23F1B gc*r» 
555 C73D023JD 0,000317 203 1.S7 401 0.231 
)» Ubeih 0.03E-O5 ?0 1.53 m 0.173 
»7 rrrt-Ndfi 0000723 eo? 1.2 324 0,250 
i£3 Epcl 0000479 410 1 «0 411 0.244 Mue mu&eiiliS «rsfcanwr of po •/tenth herrctog 1 
350 NcrtdiS QC00312 280 1.17 £>34 0.223 MUB musculo Afccch gsrta tiornolog 3 
2€0 C430Qt4K1 0,000347 7B4 1.2 203 0.2E7 
361 Vps33b 0000347 705 1.2 291 0.207 Mus muscuks M^nucUr pnotctn sonnp 338 
3€2 Ropgefll 0.Q0441 2BOI 1.2B 127 0.319 Mus musculis Rap guanne nucieoOcteenclianse 
Metsl 0000046 702 1.2 307 0.203 Mus rrurcuXrs ^5 homeotrox 1 (Nyiil), 
»4 Ctrl 2 0000723 eo9 1.2 330 (K257 
S45 Fened2 QG00532 447 1,18 387 0.249 
366 Ofodl 00001S2 16B 1,1B 640 0.203 MUB musculis cfucose-tmciBSfi coutaraducfiiso 
367 larrtl OG00471 413 1.4B 424 0.242 Mus musculis ION pcpSdasa N'tcrm^al daraln 
368 LCJCG54S42 0.00102 eos 1.2 29S 0.2G9 Mus musculis Ir/patvtk^il protein LOC654342 
3C9 Cfepn 0.000232 280 1.S7 835 0.223 Mus musculis claspn homotog 4Xer>cpus larm) 
J70 Rot>22a 0001255 924 1.21 257 0.274 Mus muscuto RAA2JA moirfew flAS vm>ya g 
*71 UtM>» 0,00093 783 1,2 295 0208 MUB mueeulrt Mbiqur»-K»n>iij8ir«| ERIIYNW E2K 
372 AeptfflS OGOOB93 739 1.2 394 0.283 Mue mueeulm ATPnft» Ca+f ifansiertiig. 
373 Slc39a13 OQOOSS2 700 1.2 313 0.2B1 MUB muiculia solua csrriar larrrty 39 (metal ton 
374 Tlol 0002599 1522 1.23 133 0.299 Mus musculis Camdu£ln4ba cnharcor al spU 
575 Mrfl 0.00037 GGG 1.10 300 0.252 Mus musculis nuc&ar RfSA. opart fadsr 1 
376 y\pioi OOOIOS7 BOS 1.2 294 0.209 Mus musculis adaptor prutcrs ccnplf j 
377 SrretcS 0.40E-O5 74 1.12 10*1 0.107 Mus mucculiB SMEK hotn^og 2. supiresocr d 
37# Uep37 00001® 170 1J5 051 0,207 Mus musculo OWquiri ep«€<fC peplifeee 37 
373 Fb«27 OGOHJS 1010 1.21 243 0.277 Mue mueciilifi F-t>0«.pnyaifi27 fFtuo27|, 
380 UttB 0000373 244 1.17 493 [>.220 MUB mu&culis i£lqulirt3U) 3 (UDI3), ffRNA. 
381 RI>S?1 0000733 640 i.ia 343 0.25G Mus musculis ras harrvdofi goto faml>\ mceTtcf 
332 Mcd24 OOOOIIS 112 1.14 832 0.187 Mus musculis mm Uxor c-orrwfcK susutn 24 
343 1(42 0.000912 749 1.2 319 0.26 Mus musculis mterfercn-lndjced pfoOstn with 
»4 Goinn 0 00u5€§ d?0 1.10 414 0.243 
Jtt G«8-rat 0000176 105 1*5 982 0.201 Mu$ muecuVa nodwrfde bnU'itg 
33D S0i24 0000673 SS9 1 10 370 0,2«0 
337 D03G044M 0003322 1775 1.23 172 0.304 
383 17CCG47I17 0000745 625 1.19 352 0.252 Mus musculis RKEN cCKA 17CCC47I17 gena 1 
117 
329 F^wrcib 7.WE^»5 B0 
590 EJat12 0.000435 364 
3*1 Snflft 0000911 740 
vn Nrrte7 0 COO 756 634 
»3 V^n?f>2 0001374 994 
294 UhiS 0 GOOB53 £47 
295 Rml aoo2sss 1E5G 
396 D0H4S114 a000927 &7B 
397 Rnttib 0.000103 103 
J96 Ifny2 0000192 1?7 
m SpagS 0 000334 301 
4Q0 2Tp1*9 00026S7 1SS6 
401 S$sm3 0000337 354 
492 f̂ pplriB Q.00U39 1062 
403 EptiM aoooi&i 140 
494 FYfcadb 4.J9E-0!. 47 
403 AS05 0 000354 300 
4C6 Ctrb* StteE-'DS 70 
407 Nell 0,00112 666 
438 Fttf2 0000175 1S5 
409 Gaiadl a000523 443 
410 Sprcd2 O.D02039 154B 
411 L>pd3 0.CUU375 340 
412 LOC-OOW4 0 002267 mo 
413 SfctfS 0000596 405 
414 R<pK2 0004576 2030 
415 EOQS7G27 9C0074S £30 
416 993CG01H0 a000973 77B 
417 BOOO2103 O.COQ295 2B4 
410 vT3!J2 0 000241 220 
419 C6XO22N0 00014J5 1084 
420 FbdlO 00006S2 £68 
421 Uhei>» 0 000237 214 
422 Nl/1 0.000115 111 
423 Apafl 9.00057 4B0 
424 Rnux£b 0.005012 217C 
4B Kbd223 a0014«9 1041 
426 Npai 0000747 627 
427 Roiiinl 0G003S 310 
473 Rcfll 0000175 157 
429 Narg1§ 7.19E-06 79 
430 Gdn aooai7i 152 
411 RpilD aeon 13 BC2 
432 111GOCOGO 0.00162 1200 
433 jVm 00016)4 1110 
434 E<*2 00006M 700 
435 C»artr 0001613 1108 
406 Tagapl 0.000226 208 
437 GrtplaD aQ00347 7G3 
418 Tbc1d23 0.0934 369 
439 G4o7 0.002319 1421 
440 0000«02 361 
441 LypdO 0 000753 631 
442 &-c5 4.53E-05 49 
443 BO aC00178 162 
444 Fdted2 9.009S2 SIB 
1.12 1(124 D.17 PREDICTED. Mus ruscuLs crokin 
1.18 470 0.233 Mus musculis SLAV (er-fcr/nnc lothd, 
1.2 323 0.2S3 Mus munrulis SKFKrte tannic |Snf1:M, mftMA. 
1.50 361 0,252 MUB muecuto Malic CHB 7. PXRTAIT 
121 262 (> 273 MUG MUEEIILRT 
1.13 3&3 0.247 Muc fruwcuVsifciqa in pfotain li^sa E3 
1.23 193 9.207 Mus musculis pnrriral Ifflcgradon sho 1 (ptnl), 
1.19 3*5 9.254 Mus musculis DXA ccgrronl, huran D4S114 
1.63 9IT3 0.19 
1.55 676 0.202 Mus rrucculiB mlerfercn gy-rra receptor 2 
1.57 599 0.222 Mue mueeglo) spew associated ewloon 1 
1 23 200 0.294 Mus mueeulie line r«tQ0f prwoin 148 lS|»i4Bk 
1,17 507 9,226 Mus musculis smal O prolan sgnnlrvg 
1.21 2S9 9.274 Muc musculis cnncin (Ttoc^aaso 1, rcguLtwy 
1.14 749 9.195 
1.1 1332 0.144 Mus musculcs (rtrtsn ijrtase, cAMP dependent, 
1.58 Si9 0.22 Mus cruscuVs ATiPacofamiy, AAA domain 
1*2 112* 0.162 Musirutcut'sc/slii w^MA. 
1.2 311 0.262 Musmu^li8ftBtwa«pt$Wr«leal iransAjflriog 
1.15 740 9,108 MUB museums eualho hariodonuin 
1.1B -£36 0.2J* Mus musculis GATA 2trc Iftgor floman 
1.22 210 0.23 Mus musculis spiculy^ctiLod, EVH1 darrein 
1.17 S36 0.222 Mus musculis LyfiXFlav dor-aln canuinrtg 3 
1.22 224 0.2D* PREDICTED Mus fruKuta stints to Enharnar 
1.50 446 0.238 Mue mueartte aigrwl iKptkto pepf»f8» 3 
124 153 0.308 MiiBmueciiUsffiCflnlwfTNFRSFMnlWBaiftg 
1.18 £Q5 9.245 MUB musculis cDNA saqusnca BC057627 
1.10 350 9.253 PREDICTED: Mus tnixuka RIKEN (SNA 
1.1G G2I 9.211 Mus musculis cONA soqucnco BCG02199 
1.10 668 9.20* Mus musculis tanned 2 CJna2l. st^NA. 
1.2 292 0.267 
1,30 431 0.24 Mue rruBGuVu F-bo< orid Asuo'ne-rieh refuel 
115 673 0,202 MUB nuiBCuliS cfciquiivcon^ajfllim) entynie E2K 
1.13 042 9.176 MUB musculis NF-fcap^AB fapTautrg fatter 
1.18 «33 9.234 Mus musculis apcpinii peptidase aclNatttg 
1.24 155 9.309 Mus musculis foqJrcd lor rmujttc nuctoar 
1.2 294 0.266 Mus musculis KAU22A. mom&er ftAS oncoom© 
1.50 419 0.243 
1.50 564 0.216 MUBrruwwVepdjinaiawsr-iiuciiui«fry 
114 704 0,10 MUB mutoiUe CIEAWFKP OND PETFYTTFANYTALON 
1.12 1170 9.1S7 MUB musculis MMDA RAOFIPGH-R&gulaied 1-ika 
1.14 837 9.183 Mus musculis gulaTute-cpstcina UJJOSO , 
1.19 340 9.25G MusmusculisrDjrJalOTalG^proaHnsfcTwiInQ 16 
1.21 263 9.273 Mus musculis RKfcN tOKA 111OOB0GO7 flsro 
1.2 282 0.268 MUB musculis ardnyon-induced pro<iAcration 
1,50 403 0.245 Mue mutculi® endoihefm 2 (E4u2K mRNA 
12 ?S3 0.267 Mus musoike eo»aftsk«Mfufl «rd Btlanor/rits 
1.15 723 9107 MUB musculis T-ctfl aclfeatan GTFuso 
1.10 390 9.249 Mus musculis N-acaWpliOOtsarnno-l-efiospftalo 
1.10 5C5 9.219 Mus musculis 1BC1 tfumanfamfj', mcrtcrZD 
1.21 239 0.29 
1.56 569 0.216 MucmusGulmfeurine-rkh repeal* ondenfcenh 
1 50 435 0.239 Mue mueeulrtLYCMPLAUR t)o*Win contf»ninij 8 
1,1 1-410 0.137 MuB mueeoliS baearudn 2 (&n62|, fliRMA 
1.14 824 9.187 Mue musculis E74-li:o tact a? 3 JEf3)t mRNA. 
1.17 473 0.232 Mus musculis FCH and tfcutjo SH3 dunalts 2 
118 
445 Rundc3t> Q.002043 1294 
446 Snla acooa» 600 
447 Pt*rt oooo«e 410 
449 Ttol 000493* 21S0 
449 Nei5 0003211 1744 
4*0 0,00074 617 
451 LCC3B1140 0.001079 e4i 
4S2 FzcllO 0,001933 1238 
453 Atr»i 0.00027 244 
454 Myole 0001656 1132 
454 FB«O34 0 002255 1377 
456 FU<®34 0000777 644 
457 AC4 Q 002844 1639 
453 Nr1d2 Q.000471 412 
459 BcR> 0.001316 SG7 
4C0 Ytd3 0.0020M 1042 
4«1 Cirkld 000!149 m 
*n Gm3*7 0000564 470 
463 Reel oooowe 6S8 
464 FbsJIO 0.0003 567 
465 311GC50N2 a001334 977 
466 n>p 0.000119 113 
4C7 BcD 0.0019* 1280 
449 LOCSOOD49 0002Kf3 139? 
440 T«22d2 0001161 667 
470 A^bp2 0000859 548 
471 Numai 0000*94 426 
472 Prkcz acoosie 437 
473 Eirc2 3.G9&OS 39 
474 •<&*• auouew 644 
475 Dusp? 0003016 18&0 
4?* Ojfiil 0000331 292 
477 Fp400 0000109 108 
47a a000849 704 
479 Gpalchl 0.0025^2 150G 
430 Cds2a a00045S 401 
4S1 Ml3 0.002113 1340 
412 llrrf 1 0001035 612 
443 EJOSCI 0002354 1428 
444 ew 0 000839 692 
445 231CC1GC0 0.002016 1282 
446 DD3OO3GH0 Q.G01099 ES3 
437 NuplSG 0.000152 13G 
438 Rst>3a O.OQ276i 1600 
4«9 Tmom23 0 0003*7 314 
4!» Vt»3*> 0,00295 1667 
491 D1300Q5M 3,165-05 8 
492 Golm4 O000217 196 
493 Emircadl 0.00121 91D 
494 CM 0,000919 705 
499 Parn aoooGto 498 
494 2fp14« 0000576 464 
49? F2H1 00012*5 989 
496 QiSdl 000015 134 
499 Cla2 a002672 1Sfi9 
560 stn 0.001351 sec 
1.21 2S1 0.273 Mus musculis KUNdofnahoortilnnfj 33 
I. SO 4)1 0.2* Mus museums tamapUoral fcgifator, SW7A 
1.0? S*4 0.22 Mus rruKulisprdinwich mictear rocvplgr 
1.23 179 9.302 Mus mueculiS ttcroductn-ito enjurnor of spit 
122 213 0,207 Muemueeultf M-aoatyireniAwaseS^DI 
1 18 «5Q 0.238 MUB MUSCULIS aqua ana <F«XCDNTA (3qto|, 
1.13 332 0.248 
1.2 295 0.2G9 Mus musculis trtzztod homafcg to JDnosapHii) 
l.M 719 0.193 Mus musculis a<r> 1 (ArtnIf. mftMA. 
!.2 399 0.262 
1.2J 264 0.273 Mus rruecuVjB r-bu», protafa 3-1 (pfe*t»34j, 
118 *53 0,235 Mue rrueeoV.e fMw«i piieteirt 34 (F$BO34), 
121 234 0,29 Mub musculis aclbauig transcr^don taciar4 
1.1G 574 0.217 Muc musculis riLCtoar recoinof sublany 1, 
1.19 353 0.2S3 Mus musculis B-col CLLTyc-phamaGj, mom&Cf 
1.21 235 0.28 Mus museums **ipee«lfcB 3 (Oniscf>hia> (YpeUX 
1.S0 383 0.2*0 Mus muecuVo casein&jnase 1.defca(CviMdX 
1.17 529 0.223 Mue mussiilja moeM 3*7, folCSl) 
1 18 452 0,238 
1155 700 0.2 MUB muficulia F-LTOIC and Dsudna-dcA recant 
1.10 351 0.253 
1.12 1061 O.IGG 
1.2 295 0.2GC Mus musculis El-cel teutamiatyrr£tioma 3 
1.21 273 0.27 PREDICTED: MUB RRUOAJLJB simly to W?ms 
1.S0 389 0.2*8 Mue mueeulj# T9C22 domait fefriljr 2 
1 17 <97 0.228 
1.1B 573 0,217 MUB mu&cuUa RFE£UAR mnetic apparatus PRETAX 
1.1G 554 0.219 Mus musculis srcrtcin Vlrueo C, zola JRjtot), 
1.09 1 G*0 0.12 Mus musculis toe I/D viral WF icpcafcccfllatilrig 
1.17 Bttt 0.22? Mus musculis Sp2 transcmnon lacloT l!ip2f, 
1.21 23? 0.20 MUB maisculfa DUAL sperifcty pNwpNilH59 ? 
US 681 0,202 PREDICTED Mue irueeufc* op«ofl flwtfh teeiof 
1 12 1133 0,t61 MusmueeuVs ElAbnd'ng prolan p400 
1.18 458 0.235 MUB musculis RAfi GTPaso oevvjang prrain 1 
1.21 253 0.274 Muc musculis G palch domain contantig 1 
1.10 GIO 0.213 Mus musculis col dwislon cydo 2 fxfnofcg A <S, 
1.2 237 0.2C9 Mus musculis nrKtalolhcfleh 3 (MI3K mRNA. 
1.56 *23 0.2*2 Mus rrurcuto Fnlerforen-fdated (SesHopnrartUjI 
1.21 270 0.27 Mus mueeuVewosome compc»>3fil ME«oec1K 
118 464 0,23* Mue muteulua «rlien«f crap locue 4 (eiW|, 
1.2 301 0.285 MUB mu&culis RKEN cCfCA 231C01GC09 gana 
1.1B 412 0.243 
1.13 995 0.172 Mus musculis rucJeflpartn IBS (KuplSSJ, 
1.21 2S3 0.27S Mus muscula RAD3A. memtw RAS oncogcm 
1.39 664 0.202 
121 2*7 0,277 Mue muaeuVrt v8tw>i*r protein rofno 330 
1 01 73117 0,021 
1.14 857 0.1 B4 MUB musculo golg* Imcgrd MARTRAFIO prolan 4 
1.19 400 0.24S Mus musculis SWl'5AF-raUr.c<J, maKti-
1.17 472 0.233 Mus musculis CDC ifto Mnoio 4 (CUdfc mRNA. 
1.10 546 0.22 Mus musculis fas apojnotic lrttbtn<y molecule 
U8 560 0.210 Mus musculis or*? frgur proton 140 (ZTpl46K 
i «0 «91 0,2*5 Mus mueeuljs eoogUeicn fB&or II t&worrb«r»! 
112 tO73 0,188 MUEMIJ6CHLT8G(YEOTSTI«NSLSRA30 8domflir> 
1.21 2S7 0.272 MUB musculo CDC2S protalfi kftasa ragblaio«y 
1.13 397 0.243 Mus musculis SET Wrtfng racier 1 <Stf1), 
119 












































O NT010 GTV_F UMCTCOJ 
Ci*.a^:ls al ihe transfer of a mottftyl group to an acccptor mcli 
C«etysij ®f the transfer erf a e<e> o methyl ̂ "P-
tntcractini; sefectftely with DNA (drcMyrtbonucfelr acid] (cold 
tr>rrcj!Di the actkviv ct a GlPato, an oniy^nc thai caulvici t? 
FuRCiiont to ceftirol ihe sufthftl, grer»th, df lew«ui«ion ira < 
Demental «tiv4ir5» tuch us coU^isor binding, cSetcribinj th 
Ct:atysts of ihe transfer a) a phosphate croup, usiHlfy from Al 
Elemental acUvtsks, such as catalysis or binding flesolblng th 
Interacting seleclwety wfl?t any rrwfldl ion |eoid 468?2| [ewSen 
brtersctlnE sdecWveV fine (Zh) Ions (said S27T>3 [evWrrKt 
Caia^ili ol iho hv\±rcU"i4 af various bands, c.g. CO, C-N, C-C 
pwl fee 










9.35 E-OS 1.9333 
983E-06 3.174 
(J.000109»:2 2.207 




IntersctlnE sdecfrveVwith any pnuesn or protein complei |a < O.OOOIS*SC<J 1.!>C?2 
tntcracilnR sdcrt^cV®1Ch a nucleotide, aTiy ccrnpcuTtd const 0.000167677 4.3£7S 
(marketing sclactfjotyitltat any proegft or praialneomplfta |a • IJ.0O0I7HO2 1.662S 
tnlerAeling S£letl«ety any p>c<ein ©r protein comply |d 1 0,0001743S8 U51J 
O.OOOl?72S9 3.2«W 
tnteractlnE selecMrtty wltft any prwetn or proleln complei |a < 0.0001X9692 5.529 
0.000 LS46I6 1.8476 
Cwatytis ef the hydrelvsii of various bond*. «tg. C-O. C-N, CC Cv000195936 1,6017 
Csie^jij of Ihe hjTSrcly« of various bonds, e c< C-O, C-N, C-C (K00021648S 2,3164 
CfiiaVsIs of the hydrdyts of various bonds. e,B- C-O, C-N, C-C &Q002S3G5 2.C793 
Cs:atysls of the hydrctv£s of various bonds, eg. C O, C N, CrC C|.0002'49637 1.537 
trcrtticat Tha activjry a GlPato. are Qn:v^rw> that catalyrcs tS D,OOOZS269l 1.7B44 
C«aVsi» erf Ihe i/enjfer ef 9 phosphate B'Oup, wswallir from Al &000?5<s©?7 2,8355 






Ciia^sls of the transfer o! a mot^ryl group to an acccptor mefi D.000340771 2^11 
a000341SS9 1.7334 
&000357242 1.7323 
















































tnteroclino selectweV wit?* an RNA rtxfecvte or a portion Iher 
tnteracUnc se4ectweV 'wltSi any protein or protein complei |a • 
Cxiatysls of the transfer of a phosphate group, usually from Al 
Ci'ntyiis of the transfer of a phc*ehate croup, UKiHlhr from Al 
Interacting sdectweV1*^ a nudcotrrfe, any coirpouTtd const 
bitaractlng idQccvo^ with a haat shock prcnoln, any guocctn s> 
Interacting $^le(t/i«V 3" WfcMiWl presto W pratgint |ge 
Sti-nutjto the exchange of cuyr/l nutleolidei by e GTPose U 
Cr.atysls of the transfer of a phosphate croup, usually from Al 
tmaracilng sctoct&ety any racial Ion |gok) 46372 j |cv3&n 
biteneiinc «letlweV lire £Zn) »©nS feoid 827DJ [«vW««6t 
trtteractinc selectweV wi$i ONA (deoriyrSbonudelc acrfl Icoid 
Interacting aHou&e^ t*leh any protein or protein complcu |a i 
tni^raeiing $«leu«efy wSt3t an RNA or a ponion iher 
tnteracUnc selectwety a nudeotitfe. BJtrccrrpowndconji 
Ciiafyils of the Iczrtlon of two substances with ccrrcamrtant b 
Oemcntal activates, such as catalysis <or binding, cfeMcnblng th 
fiJyS 0 (©"e in fegulit'o^, transcription; may bind a premier 0 
tutercctinE jdertwety *ttfh a nudeobtfe, CJrreotrpound const 
totereclino selectwety any p?otert or protein «omple« |a • 
Interacting sctcct&cy «1£h an RNA moCcaio or a portion ther 
€*iatysb of the ironsfer el d ereup,, e.g, 0 meiftyl group. efyco: 
Elemental cctm*iss> judi as totalis or binding, tfesoibing th 
tnteractinc selectiweVwIEh any m«a! Ion Icold 46872| [ev.defl 
Interacting sctactfccty ONA (dcoawlbonucJolc acttl (poll 
CMa^<i<o1ilte£>?nersfiie(1 reaction: aeyl-cartler * roeaant 
Cattfaii of the hsT&clysj of vsrbui bond), e e. C-O. C-N, C-C, 
Interacting idcctfrcty *1t9» an RNA moCeaJc or a ponion thcr 
tmaracilng wlect^eV »1tS> any metal Ion |gold 4£372| |cvjficn 
tnier*6tif»B S«letlweV *fO» p"Xein or protein «oniplet |0 < 
trteractine jdect?<eV *»t3t any n»«a5 Ion leoid 460?2| [e\'.iSefi 
Cetatfsls of the transfer of a phosphate croup, usually from Al 






















Cl 000753337 2.B974 



































































Oaatysit ol iho hydrolysis of various bonds, e.g. C-O, C-N, C-Q 
iflier*eiine seiectwety ONA (deo«^ibonucfeie *c<dl Igo'd 
Ihe selective, often stoichiometric, Interaction of a molecule * 
Qomonul actkulcs, such as catatyds or binding, describing th 
The toWtiiiy, olten stoichiometric, Interaction of a molecule«, 
Ctfetyiij of the transfer of« PHORC+MTR group, UMMIIJT from Al 
(marketing sctactfcafy line CZn) ions |gold £270] (cvldrnci 
Interesting teietlnety *fl?> 3"V rn«e1 ion |eo»d 468?2| le^Sen 
tnteractinc seiectweVwt}»a Iprf [cold S2S9][evidence l€A]; I 
A receptor that binds an eMroretular l(pnd and transmits the 
interacting selecifjety any protein or protein <oniplP« |a • 
C*!ofy)ii of the hydrdyvi of Vjrioui bonds, e g. C-O, C-fi, C-C, 
tnteractinc seiectweV *^$1 cslmcx&Jin, o caldunvbjrdtac prol 
tniaracting seiectoity any procoln or protoin complcu |a i 
tmaracilng scioctfccfy feltti zinc (Zn) lens Igold S27DJ (cMkicnct 
Function! in ehiin eioniai'en <&jring poCypepiide synhe«fc at 
tnterectino seiectwety witib ONA o£a specific nudeotstfe rorrp 
trrlerccUnc vHectr/eV»1t£i a nudeobde, acTfcorrpcuid const 
Elemental actlwlcs, such as caialysls or binding, describing th 
tmaracilng sciectfecty any procein or proialn complaa |a • 
brtereclinG seiectweV*it5i any proteri or protein compiet |a • 
•omonul activjlci, such as catalysis or binding, describing th 
Oemenul aciivttirv weh d< «niahr$'« «f binding, <a?sc»ibif(g th 
CtfleVsis of the hpirety» of various bonds, e b< C-O. C-N, C-C, 
11% setecthw, often stoichiometric, interaction of a molecule % 
Interacting sctcctfccty *1tfi an RNA mcfcaic or a ponion thcr 
Interacting sctoctfcafy any procein or proioln complfu |a « 
Interacting 4<lett«efy ATP„ adenosine n 
brteractinE sdectweV'WtSi a nudeobde, trrf corrpoLrx) oorm 
Sti-mibtes the ecrhanfe of cuarryl nucleotides by a GTPase d 









































0,091 SOI 8 1.57*5 
0.001MW94 3.0278 
0.001507728 1.5638 














































ferter«ctine sefectwefy si nudeolidie. mrf compound oons'r 
IrrteracUne selectwety witii any proteti or protein complei |a • 
Interacting sdcctbcty *1tt» a nudeotirfe, arrf compound const 
Imaractlng selecthaty any proton or praialn complai |a. 
Csfiotyjis of the transfer of a phosphate eroup. usually from Al 
InteractinE sdectfcety »1t*i any rrvKal Ion (cold 46S72| [evidwi 
Intoractlng solactfccty <*1th monomcjtc or muhlmaric forms of 
Catafyti? 04 ,h® ean<tar of» plio«plwt« group, brouallf from Al 
ferteraclinc sdectwety will) any ptote'n or protein complei |e • 
tnrteracUnB selectwety with any preten or protein compiet |a • 
tnterKlinG&eleaweV^i^dnvpTOterior protein complei |0" 
terterxtinE sdectwety with one (2/>) ions (Bold 8270) [evvdmci 
Ofiafysls of the transfer of a phosphate Eroup, usuilhr from Al 
CMatyf'f ot th« trantfar of» ptio«pha(« group, usualVr,om Al 
tnter«cline selettweV with ONA ot a specific nudeobde romp 
interacting $eiect»eV with ONA (deei^ibonuetaic ackfl leend 
krteractinB selectweV with an RNA rncfecule or a portion Iher 
Functions In the WtUtton of rlbosofnc-mecijted translation o 
Imaractlng ariactfecly w1t*i any protein or protaln complai |a i 
b>er*afQ< th« aeiiv^y of a GTPao, an emym* that catalym it 
Ctffl^sis of the reaction: MAP kin«s« serine/lhreonine/lyroiir 
Casatysls of the transfer of a group, e.g. a methyl group, glvca: 
Tho satoalv*, oftan stoichiometric, Interaction of a molccula t 
trteraclinG sdectwety wibh GTP. giranowne triphosphate Igoid 
Elemental actlvites, such as catalysis or binding describing th 
Casatysls ot iho genar«fl:ad reaction: acyl-carrtar t rcanant a. 
Interacting wflh any protein or protein complai |a > 
Increases the «ctiv*ty of a GTPaie, un enijme theft rafcjIjTW U 
CssaWsIs of the hi^njlysa of various bonds. e^E- C-O, C-N, C-C 
Mediates the transfer of a slgral trom the outside to the tntfffi 
Imaractlng selattfeoV with line (Zn) Ions Igold S27D] (culdanci 
terteractinc sdectwety with monomeric or muhimera: feirro ot 
Casatysls of iho hydrclysns of various bonds, «.g. CO, C-N, C»C 
(X0015M7S1 




































































































































Increases Ihe eclivity of a GTPase. an eniime then C81JHT» ti 
Interacting idcctwcty with GtP. guanotlne triphosphate leofcd 
Interacting sdcctfrcV w10> zinc (Zh) Ions [gold S27D) (ev Wcnci 
tmoractlng sstect^efy wliti a G-protsIn-coupted f atopics |golt 
Interacting Vfle<t'«eV with OTP, ftirtnosine ir^hosphftle |e®W 
Interacting sflgctneV with any protein or protein comply (a i 
CaseW) of «n wrdjt«cm-reAicliGni Oedo*) reaction a sewjil 
Enables the active transport of a solute across a membrane b* 
Interacting sdcctfccty wltSi an RNA mcfcaJc or a portion thcr 
interacting setectwety with ONA (dcotyvibonudeic ccicfl Ipati 
EJomanul activates^ sutfi as catalysis or binding, describing th 
Imaractlng Ktacti-iOty wltft rmgnKkm (Mg) Ions (gold 287} (a 
Interacting s«teuwetywfth calcium ions |C®2*} Je^dSSODI lev 
Qemental actlvJla, such as cota^s or binding, (describing th 
imaractlng sdactfccty wltti a nuciaotido, any ccrcpoundGonst 
Interacting $#lectM$ty wftfi an RNA rntfecUe or a ponion iher 
bilerfctino selectwety wit#» a protein C-t«*rrinus, the end of BI 
Ctfatyjls of ihe transfer of a rnetfT^I group to an acceptor molt 
Caiatpsls of the transfer of a phosphate group, usually from Al 
imaractlng sciactfeoty wftti any pnxoin or protaln complai |a i 
elemental activates* *u<#» es <atal»-$ii«' binding, describing |l» 
Interacting selectively witSi ONA (deoiyribonudeit ecd) Igosi 
Interacting selectwety with any m«al Ion (gold 46872) [evufen 
Casatysls ol movtimant along a polymcrk molceute such as a n 
lnter«lin|j seiettweN wi$i calcium ions |C«2+] Icod 55091 lev 
Interacting selectively witSi zmc (In) tens [gold S270] [evldertci 
Increases iha aetiujy of a GTPase, an onzyme that taulyisi tf 































0.0029 SO 135 2.0193 
0,002971007 1.59&4 

























































OemenUl •cliv^iei, such bj catahrvi or binding, describing th 
imcracilnR sdcctfccty with zinc (Zfr) Ions fgold S27D) (cvktcnci 
interacting «le(t«eV anv protein or protein <omple« fo • 
Interacting with jinc (7r») Ions [gold 8*70] [e/itlfrtCi 
frrleracUnc fHectwety with one (Zn) tens [cold S27D] [evldenci 
C»a^iit cA the hydrolysis or various bondt, *.g. C-O, C-N, CC, 
Interacting sefectwefy with dirornattn, the network of fiber* o 
Caftatysis of the transfer of a phosphate croup, usually from A1 
Ca;atysls oi iha tranilar crt a phosphate group, usually from A1 
Th* runeiion of a trame£p(ioncofaaor thai nji wsie* iran*si^ 
OemenUl •cljwtiev tuch UJ colttlyv) or binding, dewibinf th 
Increases the activity of a GfflPase. an enzyme that catalyzes t? 
Ocmcnul activates, such as caiatysls or binding, describing th 
Imaraciing »1act^o^ *lth 3 nuciaotida, attf compound const 
terterectinc selective*/ with cilaum ions fCo2+} |pcd SS09I lev 
Interacting selertwety with a Ipid fgold S23S] (evidence IEA] 
Functioni to Initial* or regulate RJ4A polymer*** II trarncr^pitii 
Inlerccting selective*? with un DMA mtfecule or a portion Iher 
C^taVsis of the reaction: AtP • a protein i^riosAhreonmr = A 
Interacting sdcctfr c V with the beta subuntt of the catcnft cot 
Interacting s«lea«ety with 0 nonidenlic-dl protein to form • N 
OtfoVsii of the transfer of a croup, e.g. a methyl group, gtpco: 
Interacting sefectJvety with any prccefi or protein cample* |a • 
imoractlng ssioctfccty with ONA (dttxcyrlbanudolc add) (go'*) 
Interacting <*l0Ct"«efy with n'nc (7r») ions [goid £270} [#vWw*i 
Criafyiis of the hydrolyyi of various bonds, e g. C-O, C-rt, C-C 
Intoracilng sstactfeaty with any pfoceln or prataln complcu |a < 
Caftofysis of the transfer of a phosphate group,. usually from Al 
Interacting selectively with an Identical proceh or proteins |gc 


























































































Ctftatysu of the eewrtfijed rea ction; dcyl-cumer *• rodent a. 
tnteractJnc select»1th any prcteft or protein compter |a • 
The selective, often stoichiometric; Interaction of a molecule k 
Imaraciing telacts/aty •mlrh any protein or proialn complo< |a« 
Interacting selettweV £Zn) ienS {goid 8270] [cvidenei 
Gafiotysis of the reaction: HAD* »|AW-D-nto»yl]fr>)-acceptor: 
tntcractine sHcctwcty *1t?i!he gamrna-amlnobutyrl: acd (GA 
Ca:a^:li oi ATP-dopandont liopapttda bond formation bar*o 
Wjys a roe In re cutting transcription; may bind a promocer c 
imaraciing sctectyjofy ••1th GTP. guantKlna trtphoiphaia (g-aid 
Interacting seletl«ety *)nv p»<xe*n or protein comple* |0« 
fcrterectine select##ety »ith any HI«B! ion feokl 466?2| [evden 
Interacting $*la«fcety «"V protein or protein comple. |e. 
CcSofys'I of the transfer of« Efo«*i., C«B u methyl group. CKKO: 
Calatyjls of movement alone a polymeric molecule such as 4 n 
imoractlng selcctfecty i*1tt> ONA (dcarvtlbonudclc acttl I pad 
Imaraciing Mlect^aty <«1th any protein or proialn <ompla« |a i 
ClflOV^iS of the t/en&fer Of 4 phosphate group, viuilly from AT 
Irrleracllns vHect^ety'*1t?h any rr»«al Ion [fiald 468721 [evden 
imaraciing scfoctfecV 'fcltfi an HNA mtfoaia or a ponlan thcr 
interacting $#leu»e>y »H1» any nucleic acid (goid 3676| [ewda 
Intersclinc s«lect«ety vntSi any n««atlon [gold 4G872I [evden 
Interacting sdoctfrcV *10» any protein or protein complct |a • 
imaraciing fislactfeety ••1th any protein or praialn complai |a i 
tnluraeiing selettwety fine (7n) ionS [goid 8170] [evidenei 
Interacting selectwefy an RNA mcf eaie or a ponlan ther 
imaraciing sctoctfccfy <*1th any mtsal Ion Igold 468721 |o*,Gdcn 
Th« runciion of a uanvrption cofaaor ihat atijvanec uafwsr^ 
the function of binding to «specific ONA sequence order to 
imaraciing seiaebbaty an RNA mcCaaia or a portion ther 
HteractinE sdectwety wit:?i a nudeobrfe, «cvtorrpo«ndoonsi 
imoractlng sdoct^cV '•1® ONA (dcarvrfbanudoic acU| |god 
(X004261S01 2.16SS 


























(X 0047*3936 1<6**2 
0.00 <3754 927 2.992 
0.004957174 1.5012 
a004B52794 1.75S4 
0.00466 JOW 3.4412 

























































biterectine sdectwety wit^i one £Zn) ic«i [gold §279) [cvfetrrKi 
tirteractlnB select!wety»1t5i any nw?a1 Ion IcoW 4G8'?2| [evdeti 
Ct:alyils oi the htfdrclvii of various bonds, eg. CO, C<N, DQ 
tmaractlng selectively wltft any nrjckic acid [goid 3676) |6vuSe 
Hke ferinui ixti ot o protein d'mer. * rnteromclef olfTJ JUuetvre 
brteractinB sdectwefy witJi an RNA rrcTecde or a portion ther 
tirteractlnB sdectjvety with any protein or protein complu |a • 
EJomonul actKulcs, such as catalysis or binding, describing th 
Osteosis of the h»TSrcly» of vjrioui bond j, * B' €-0. C-N, C-€? 
Ctlafyjlj of the hydrclsis of various bands, e.6. C-O, C-N. C<, 
interacting sdcctfccty *ttJi any protein or protein compln (a • 
Enable* the *tk« uanfpcrt oS a tolut# a membra b\ 
Cstatysis of the reaction: ATP * a sn«ein ierbwAhreonine = A 
Interacting aHcctfcicty*tt3i rfitc CZh) Ions [gold S27D] [cvktcnc* 
Casatpdt ot iha tranilar o1 a grou^, e.g. a moifcyl group. g)v<oi 
CstaVsis of the transfer of a srou®, e.g. a methyl group, ilyco: 
Crisis of the reaction: ATP * ublqultto • protein tystr»e = AN 
The selective, often stoichiometric, interaction of a molecule * 
trrteractinE sdert«cV»it5i ONA (deafydbonudelc acid J lead 
brtoracilng sdcct&cV*l&> ONA o4 a specific nudcot&c ccirp 
tmaractlng actact^Bty cm© or «nt>f» ipodllc sites on a rcti 
Slopi, pr«vn«Ji©f reduce* Ike festivity 6^3 protein phoSphO'4 
Oemental octivtin> such ascalahr»ior binding, deityibini th 
tmeractlnB setectwety wltfh any protein or protein complet |a • 
tmaractlng sctactfccfy *1£h iSacytgl^crol, a dlostor ot glycerol 
Interacting s*lea«eV *1tfc line C*nJ iens [goid 8170) 
tnlersclSnc selectwefy *it3t ONA (de«r«y<ribonudeir Icod 
tmeractlnB selectwety *itS» any protein or protein complei |a • 
tmaractlng fitfact&ety &nc (7") lots (gold S270] (cvfcfsftct 
interacting $eleu»efy any m«&! ion laeid 4gs?2| [evjfisn 
C&taVsis of the hyiirclysj of various bonds. e.6- C-O, C-N, C<, 


























































































IgQjd 8419| lewtacnce IDA^ GaUls'ii of the hydrops of varGoi 
©f Ihe transfer ©! a gre^ e.g. 0 methyl group, ftlyeo! 
Csiatyiij of the hSBtion of two subUsnce wnh ccreomrtant b 
Canafysls of the hjtlntfvsi of various bands, tg. C-O, C N, C«C 
Ca:afysit ot tho Ration of two substanccs whh ccncomhant b 
Interacting sefectweV witSi arc (2n) lens (said S270} (evkferct 
Caia^sls of the transfer ofa phosphate group., usually fntm A1 
Interacting seJectwefy with ONA (drcrryribonudelc ocid) |go*d 
Cuatysls ot iho hydrdv£* of various bands, c.0. C-O, C-N, C*Q 
Eli)fiiontal aeiivjiev UIC^I d( C8isf>-sii or binding, ajsc* ibif\$ th 
trrter«ljno selective** wi$i any protein or protein <on»ple« |a • 
The function of binding to a spcdffc ONA sequence iii order to 
Interacting icloct^etyanV pnjee"n or prataln cornplfu |a t 
Elemental «6ljv£5ie$» §u€h 81 «8t0hrwJ or binding, <Se$cribins th 
bTlerocting vHectwety *it5i ONA orf a specific nucleotide rcrrp 
Cr.afyils of the transfer of a phosphate group, usually from A1 
Elemental ocliv^ir^ tucH us cetah^s <" binding, deuziblnz th 
Interacting sdcctfrcV wtfti DNA (dconysrlbonurfGlc add) I pod 
CKatyilt oi the hydfclvis of various bands, ©.g. C-O, C-N, C-C, 
Interacting S«lettwety wit?* any p»C*ein Or prolein «ontple« |d • 
Cssatysls of an ojiffiattan-red'jcUcn (redovO react on In *t?lch h 
Tmc solccilvo, often srolthlamofcjlc, interaction of a molrculc t 
OemenUl ostites, tuth a» celahnls or binding detoribine th 
Interacting sdcrt&cty Iran |Fc) Cora fgold 5506] He^tdcnci 
tmaractlng «toct*ie»/ any rr-Kki'c acid Igaid 3676| lovMa 








































0.00 B44736 2.2513 





390 Wbpll bitertelinc sdettwety *ith any P"*eri or proiein comple* |a • 00086)4151 1.6877 
397 Cnott Uemental ocUv.llc% such as calahreis or binding, describing th 0.0086S>SSSS 1.9WS 
398 Dna|cL3 Ocmcnul acllvtlcs, such as catalysis or binding, dcscr1bln£ th 0.0aBBS9135 1.9207 
399 A/peia tniaraciing sciactoety wit?l monomelic cr muhlmarx tama oi (X00BS934S7 1.5*57 
400 GiiJ b)tt>r*eiiii0 j«4e(t«efy OTP, ftiAtntttine tf «<ho>ph«rie |goid 0.000705976 <07 
401 Mfsdl Enables the directed jnorement of j&Aslanres (such as rnocra 0.008/10126 1.5S16 
402 Tgfbrl Interacting seiectwety magnesium (Mb) Ions (cod 2B7| [e 0.008727272 3.1G05 
403 Puml Interacting sctoctfccV *»1Bh an HNA cnaooda or a ponlon thcr D.00B757S57 4^473 
404 »3C036H55Rfc a00BBU>l3 1.6607 
40S finpjl brter^clinc selective** with ONA (decr*)Tibonude*r «c"d1 Ipnd 0:00881 iW6 1.6*4) 
40G Rngtt Ca'aVils of the Hi^clvts of various bonds, euj. C-O, C-N, C<, 0.0088SM2J 1.92<r9 
407 AO 03 Interacting sdcctfccty rrwrwrncrtc or muhlmcrCc forms ot O.OOBB21649 2.052S 
408 tlmfc2 Ca»ty tit ot iha transfar o1 a phosptat« group, usuilly tram A1 Q.MBB537D7 1.917 
409 Axnl Mediates (he UOnjfer of * iifirial from Ihe QutVCfe to the rryif> a008912992 2.J«97 
410 22l04l9D2J£fe O.OO09S9W 
411 Vtorcllii O.OOB9542E9 3.&3S1 
412 Rab2a tmaractlngsciottfcctyialttta nudaoCde, any compound const 0.00912S471 1.8324 
413 Et*s Ifttef a«iing w!i>i ONA (deoiyvibonucteic «id| |go"4 0k009l J2444 3.8091 
414 493056301011* 0.009179913 2.0587 
415 Scrpf Interacting seiectwely wt$« an RNA mofectrfe or a portion Iher 0.0091SS184 1.900S 
416 Rras Interacting sdcrtfcc1y<*1t3iGTP, guanoslnc triphosphate Igald 0.00919S443 1.9BtS 
417 2?p2ai •amantil acllvOUss, such at caiatpilt or binding, de*criblf\g th 0.00922C&22 2.5059 
418 2mym3 Interacting <*leU«ety *I*J» 0nv nrw«6l ion |tjoid 46972) [euiSen 01.009224237 1,7759 
419 ttvS Interacting se<ertwety*it5i ONA (dccrytribonucfeic ocid) IgoiJ 0.0092S92S3 2.0627 
420 Mil 2 interacting selectftefy an RNA moteaJe or a portion Iher 0.009323496 1.8072 
421 Ppmlh Ca:atysls ot tho tn^drclyis of various bands, c.g. C-O, C*N, C-C, 0.009551125 3.2672 
422 FP8* tntgraeiing wllh 3 nucleotide, artf (oiRpound oonw 0.000397544 1.612 
433 OnijcS bUereclino selettvehr «wlh 4 heot shoe* pneflein, any protein v ft009S9«»l 1,9667 
424 B3£P19 CanaVsIs of the transfer of a gnajp, e.g. a methyl group. gis<co: 0.009£50109 2.6JS7 
425 SJc25al6 The selecilve. often ssolchlomcBlc, Interaction ot a molcculct 0.009C9SSSS 1.8205 
426 Ba$4 Imaraciing sclact^aty *1tti any protein or prataln complfti |a. IX 009534934 2.37.53 
427 Nme7 CMBfy Si) Of the Ir^njfer of 4 phosphate group, vftMlly from A1 0,009587453 2,4459 
428 Nrddl 0.00900 VW9 4.6777 
429 flcsl6 Mediates ihe transfer of a slp^al from the outsdr to the *ts(T> 0.009617749 1.5556 
430 c»4isii •omonui actlwlcs, such as calami or binding, desolblog th 0.009B942S6 1.96S9 
431 Cief Interacting $tl8U*ie»r witti any metal Ion (goid 46672) |«vd?n a009775»?6 1.64S5 
492 C6S0012N070ik <X009807M4 2.3*79 
433 Mllt4 Interacting sefectwety *it5i any proten or protein complex )a • 0.0098S0438 2.07n 
434 EGK7299 0.009391559 1.9049 
435 Slc40al Interacting fdac&aty »1tti Iron |Fo) tons (gold 5506) getldHtei IX00992G966 2X193 
436 Piekhal Interfering sdettwety o Ipd [goid ?2S9) (evidence IEA) 0.0099J0022 2.742) 
437 AaiiJ Uemenfcal ecUNttie^ such as cutalyiis or binding, dncribinc th 0.0099S1616 t.on 
438 Pifcctpl Interacting seiectftety *1t?i any metal Ion Isold 46S72) (ev.deti 0.00993035 2 1.851S 
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Appendix C: Overlap of enriched Puml and Pum2 mRNA targets 
1 Cidspl 42 LOC100047200 83 5ei<)2 124 Rabllb 165 Aoafl 
2 Rasoipl 43 DMAbble 84 lllOCOlAOTRik 125 Chic 2 166 NarfjU 
3 lmsl2 44 Pntdcl 85 Med4 126 Elawz 167 Gc2m 
4 Trio 45 Q d f  86 Arhee^ll 127 DcunliM 168 Rgsl6 
5 UtS2 46 TmemlBS 87 IOC1OO0449S8 128 F63QQ43A04R»V 169 1110015G07Rik 
6 Zfp532 47 4732462BOSRIk 88 Stc36s2 129 4921505C17R«k 170 Aprln 
7 1ta3 48 Savl 89 Sftl7b 130 Aft3a 171 lrch4 
a LOC1C004&&93 49 Ippk 90 Hhcv 131 Tbkl 172 &*<3a 
9 Bcl2lll SO Ahdcl 91 Ensa 132 Sqlc 173 Prar2 
10 DQi0063EU SI LinS4 92 SklSalG 133 Uspl 174 NatS 
u Nfkbia S2 AI4S0540 93 Dcpdclb 134 ItgbSbpl 175 Axiril 
12 AI413S82 S3 4933428G2QRik 94 MapSk3 135 3&30431G2l(Uc 176 Mvole 
13 4930563B10Rik 54 Cdc7 95 Zfpl31 136 Clstn3 177 R>raJ4 
14 Zfp292 55 Radl 96 2410042D21Rik 137 Cbfb 17B Ypefl3 
15 Rheb 56 2210419D22R3t 97 Tiki 13B Cv*fl901 179 Cuikld 
16 Zfp6Q3 57 EiMenafl 98 Sk40al 139 Stf 180 Pia&l 
17 r<w|3 58 Ube2(ll 99 Spc25 140 Hmeb2ll 181 Tbp 
IS rmpi 59 Aebo2 ICO 8»dC2 141 Cetfipi 182 TiC22d2 
19 Puml 60 2810485l05Rih 101 CdW 142 2310016008R>k 183 Pfka 
20 TfBppcSb 61 OenteB 102 Grt3 143 Epcl 184 Dusp7 
21 COfl3 62 NCttn 103 Cramp 11 144 Vps33b 185 Ep400 
22 C33KW9H01Rlk 63 So:<2 104 1rak2 145 Fanod2 186 Rabgapl 
23 Ok2 64 phfia ICS Kifli 146 LOCSS4&32 187 Cdc2a 
24 Bcl6 6S Pvcd3 106 TmomSSb 147 Clspn 188 Euoscl 
2S Syvnl G6 LOC1G004S797 107 Schipl 148 Ube2k 189 CtM 
26 Skil 67 Nudt4 108 Mum 149 Tlel 190 DG30036H09Ril 
27 F:d7 68 Pik3c3 109 OuapG ISO Aplsl 191 Sonajradl 
28 SlcJOaS 69 Setdla 110 Bbc3 151 Fbw>27 192 Kif2a 
29 Irfl 70 Rbm5 111 Cedel26 152 UW3 193 9330160L10R3. 
30 Dnt«31 71 Pwllb 112 Eico2 153 Rhotl 194 Nodal 
31 Kit 72 4930539EQ3IUk 113 17O0€47ll7Wkll54 Med24 195 Zlp644 
32 Sdadl 73 rati 114 LOC100047934 155 Pprnlb 196 Ptpn6 
33 Pcef2 74 Mysnil 115 Bfpfl 156 Nme7 197 Sap30l 
34 ugce 75 MII3 116 Usperil 157 Pfkacb 198 Gtsel 
35 IOC237877 76 Vkorclll 117 Etv5 158 Atadl 199 Bhlhb2 
36 OHF61 77 Gas6 118 Neddl 159 Ccnbl 200 A*3J?1 
37 Klflb 78 Sox21 119 Taf5 160 $J>P© 201 Hesi 
38 Klf20b 79 Dab2lp 120 Adnp 161 BCC021&9 202 Slk4 
39 Orf.6 80 Purn2 121 2ai0403ft07Hlk 162 C633D22M07Rilc203 Wvstl 
40 Ptchl 81 Rahgcfl 122 la oil 163 FbKllO 204 Zcrbl 











































MS52 247 LOC675933 288 Aaas 329 TriplO 
Isml 248 SiahSa 289 <J950430F€SBih 330 Senp2 
papefg 249 psep 290 Sk636 331 Ppmla 
C91C001AC6RI>: 250 Rmi2 291 D15WsJl69e 332 Afpcla 
Slahlb 251 Ple&hal 292 Psmg2 333 Bctafl 
Phf3 252 ZczhcB 293 D<£<26 334 My«4 
Numb 253 S43340SG24R& 294 Mc:tl3 335 E2f6 
Tgfbrl 254 OUid4 295 Arhgo53 336 WdrfiS 
9150lSGA19Rik 2SS Ppap22i 296 Atplbl 33? LDCl<Q0O<35O£d 
Snipl 256 KIF4 297 Trim2 338 Dbrl 
TmcmGO 257 ArfgpfS 298 Anp32a 339 S / f f l  
Nptn 258 Gtdsp&2 299 RIn2 340 \Vhsc2 
Kbtbd2 259 Phoctr4 300 Dk*3S 341 Sifflla 
E430Q05l09fUk 260 LOC1COQ45542 301 MarVba 342 T>3Hfcl3 
Med31 261 Tef4 352 Cd9 343 PrJS 
Fbao3 262 Btf3 303 Ineenp 344 A^p 
Ca3kin2 263 901MCM003R3i 534 8ag4 345 Hft> 
rein 2§4 rbxo31 3S5 2610039C10RiK 346 Wbpll 
Arppl9 265 23HJ003C23RII: 306 lfil<H3©9l24Hik 347 <5ak 
BC032293 266 FPB5 507 Goraspl 348 C«0l2 
Pdcdio 267 15 mS 3S8 Mgeae 349 Uvl 
Sfrr.5 268 CS3G028l0J3Ri 309 Zrr^TnB 350 lOC10IXWfi613 
llc4 269 Tuft I 310 Cchpfa 351 PrrB 
AKJI2 270 litis? 311 LOC100047707 352 Vpi2€ 
YeaisA 271 Mllt4 312 Add! 353 Sjmcii 
Gtf2h2 272 Nup89 313 354 23lOCO?OHRik 
CG627299 273 Map3kl 314 HplbpB 355 Tiaml 
Qb*2 274 CloviS 315 Mojc3 356 D120C63H01Rik 
Fb*ll4 275 leal 316 sd0CO911_1^939J57 Gtf2irdl 
U$p42 276 11100690 OS Rik 317 Rpn2 358 Clef 
Zft)512 277 2610305D13R&318 Kif22 359 Znwni2 
Kl'5 278 Vamj»4 319 Ppp3rl 360 SnxlO 
5U212 279 StaCpl 320 Uck2 361 D15Erid&2le 
IOC1G0048299 2B0 IOC1C0040592 321 PpplfS 362 Dfta^>l 
R£prr<td2 281 <3113 322 W35I 363 DyncUZ 
DnaJaS 282 NcapdS 323 TrpS3lns>l 364 Phca 
Acsll 283 Tf3p3»G< 324 Ipb4,9 365 Prkdbpl 
FnbpBB 284 Atmin 325 Ncaph 3S6 Rab2a 
LL?nk2 2BS Pibjil 326 LQC1Q0CW7911 
Ep320 2B6 Prpf4 327 Ccarl 
Ahnak 2B7 Frrl 328 LOCSGGG76 
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